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PREFACE
The Occupational Safety and Health Act of 1970 emphasizes the need 
for standards to protect the health and safety of workers exposed to an 
ever-increasing number of potential hazards at their workplace. To provide 
relevant data from which valid criteria and effective standards can be 
deduced, the National Institute for Occupational Safety and Health has 
projected a formal system of research, with priorities determined on the 
basis of specified indices.
It is intended to present successive reports as research and 
epidemiologic studies are completed and sampling and analytic methods are 
developed. Criteria and standards will be reviewed periodically to ensure 
continuing protection of the worker.
I am pleased to acknowledge the contributions to this report on 
inorganic arsenic by members of my staff, by the Review Consultants on 
Inorganic Arsenic, by the ad hoc committees of the American Industrial 
Hygiene Association and of the Society of Toxicology, by Robert B.
O ’Connor, M.D., NIOSH consultant in occupational medicine, and by Edwin C, 
Hyatt on respiratory protection. The NIOSH recommendations for standards 
are not necessarily a consensus of all the consultants and professional 
societies that reviewed this criteria document on inorganic arsenic. Lists 
of the NIOSH Review Committee members and of the Review Consultants appear 
on the following pages.
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The National Institute for Occupational Safety and Health (NIOSH) 
recommends that worker exposure to arsenic and its inorganic compounds, 
with the exception of arsine and lead arsenate, be controlled by requiring 
compliance with the following sections. The standard is designed to 
protect the health and safety of workers for a 40-hour week over a working 
lifetime. Compliance with all sections of the standard should prevent 
adverse effects of exposure to inorganic arsenic in the workplace air and 
by skin exposure. The standard is measurable by techniques that are valid, 
reproducible, and available. Sufficient technology exists to permit 
compliance with the recommended standard, The standard will be subject to 
review and will be revised as necessary.
"Arsenic" is defined as elemental arsenic and all of its inorganic 
compounds except arsine and lead arsenate. "Exposure to arsenic" is 
defined as exposure above 0.01 mg As/cu m.
Section 1 - Environmental (Workplace air)
(a) Concentration: Occupational exposure shall be controlled so
that no worker is exposed to a concentration of arsenic greater than 0.05 
mg As/cu m of air determined as a time-weighted average (TWA) exposure for 
up to a 10-hour work day, 40-hour work week.
(b) Sampling and Analysis: Procedures for sampling, calibration 
of equipment, and analysis of arsenic samples shall be as provided in 
Appendices I and II, or by any method shown to be equivalent in precision, 
accuracy, and sensitivity to the methods specified.
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Section 2 - Medical
Medical surveillance shall be made available as specified below for 
all workers occupationally exposed to arsenic,
(a) Preplacement and annual medical examinations shall include:
(1) Comprehensive or interim work history.
(2) Comprehensive or interim medical history,
(3) 14” x 17" posterior-anterior chest X-ray,
(4) Careful examination of the skin for the presence of
hyperpigmentation, keratoses, or other chronic skin lesions. Skin 
examinations shall be repeated bimonthly. Care shall be taken to observe 
and record the location, condition, appearance, size, and any changes in 
all such lesions.
(5) An evaluation of the advisability of the worker's using
negative™ or posltive-pressure respirators.
(b) Proper medical management shall be provided for workers
exposed to arsenic,
(c) Initial annual examinations for presently employed workers
shall be offered within 6 months of the promulgation of a standard
incorporating these recommendations.-
(d) The medical representatives of the Secretary of Health,
Education, and Welfare, of the Secretary of Labor, and of the employer
shall have access to all medical records. Physicians designated and
authorized by any employee or former employee shall have access to that
worker's medical records.
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(e) Medical records shall be maintained for persons employed one
or more years in work involving exposure to arsenic. X-rays for the 5 
years preceding termination of employment and all medical records with 
pertinent supporting documents shall be maintained at least 20 years after 
the individual's employment is terminated.
Section 3 ~ Labeling (Posting)
(a) Containers of arsenic compounds shall bear the following label 




HARMFUL IF INHALED OR SWALLOWED
AVOID CONTACT WITH SKIN, EYES, AND CLOTHING
WASH THOROUGHLY AFTER HANDLING
Avoid breathing dust or spray mist
Keep container closed
Use only with adequate ventilation
(b) The following warning sign shall be affixed in a readily 
visible location at or near entrances to areas in which there is 
occupational exposure to arsenic. This sign shall be printed both in 





High concentrations of dust or spray mist 
may be hazardous to health.
Provide adequate ventilation.
Section 4 - Personal Protective Equipment and Work Clothing
Subsection (a) shall apply whenever a variance from the standard 
recommended in Section 1 is granted under provisions of the Occupational 
Safety and Health Act, or in the interim period during the application for 
a variance. Until the arsenic exposure limit prescribed in Section 1 is 
met, an employer must establish and enforce, as provided in subsection (a) 
of this Section, a respiratory protection program to effect the required 
protection of every worker exposed.
(a) Respiratory Protection: Engineering controls shall be used to
maintain arsenic concentrations at or below the prescribed limit. 
Appropriate respirators shall be provided and used when a variance has been 
granted to allow respirators as a means of control of exposure in routine 
operations and while the application for variance is pending. 
Administrative controls can also be used to reduce exposure. Respirators 
shall also be provided and used for nonroutine operations (occasional brief 
concentrations above the time-weighted average or for emergencies). For 
these instances a variance is not required, but the requirements set forth 
below continue to apply. Appropriate respirators as described in Table 1-1 
shall only be used pursuant to the following requirements:
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Table 1-1
Multiples of TWA Limit 












(1) Half-mask respirator with replace­
able dust or fume filter(s)
(2) Type C demand type (negative pres­
sure) supplied air respirator with 
half-mask facepiece
(1) Full facepiece respirator with 
replaceable dust or fume filter(s)
(2) Type C demand type (negative pres­
sure) supplied air respirator with 
full facepiece
Powered air-purifying (positive pressure)
respirator with high efficiency filter
Type C continuous flow (positive pressure)
supplied air respirator
(1) Combination supplied air respirator, 
pressure-demand type, with auxiliary 
self-contained air supply.
(2) Self-contained breathing apparatus 
with positive pressure in facepiece
(1) For the purpose of determining the type of respirator 
to be used, the employer shall measure the atmospheric concentration of 
arsenic in the workplace when the initial application for variance is made 
and thereafter whenever process, worksite, climate, or control changes 
occur which are likely to increase the arsenic concentration; this 
requirement shall not apply when only atmosphere-supplying positive 
pressure respirators are used. The employer shall ensure that no worker is 
being exposed to arsenic in excess of the standard because of improper 
respirator selection, fit, use, or maintenance.
(2) Filters used shall be of the appropriate class, deter­
mined on the basis of exposure to arsenic dust or fume. If exposure is to 
gases and vapors in addition to arsenic dust or fume, appropriate respira­
tors shall be selected and used for protection against these agents, also.
(3) A respiratory protective program meeting the general 
requirements outlined in section 3.5 (Minimal Acceptable Program) of 
American National Standard Practices for Respiratory Protection Z88.2-1969 
shall be established and enforced by the employer. In addition, Sections 
3.6 (Program Administration), 3.7 (Medical Limitations), and 3.8 (Approval) 
shall be enforced.
(4) The employer shall provide respirators in accordance 
with Table 1-1 and shall ensure that the employee uses the respirator 
provided.
(5) Respiratory protective devices described in Table 1-1 
shall be those approved under the provisions of 30 CFR 11, published in the 
Federal Register March 25, 1972.
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(6) Respirators specified for use in higher concentrations 
of arsenic may be used in atmospheres of lower concentrations.
(7) The employer shall ensure that respirators are
adequately cleaned, and that employees are instructed on the use of
respirators assigned to them and on testing for leakage,
(b) Protective Clothing:
(1) Where needed to prevent contact dermatitis from arsenic
compounds, protective clothing shall be provided by the employer. This may 
include underwear, gloves, coveralls, dust-proof goggles, and a hood over 
the head and neck. When liquids are being processed in a manner that may
result in splashes, impervious gloves, aprons, and splash goggles shall be 
used.
(2) Protective clothing shall be changed at least daily at 
the end of the shift,
(3) Work clothing shall not be taken home by employees. 
The employer shall provide for maintenance and laundering of protective 
clothing,
(4) The employer shall ensure that precautions necessary to 
protect laundry personnel are observed when soiled protective clothing is 
laundered,
Section 5 - Informing Employees of Hazards from Inorganic Arsenic
At the beginning of employment in an arsenic area, employees exposed 
to arsenic compounds shall be informed of all hazards, relevant symptoms of 
overexposure, appropriate emergency procedures, and proper conditions and
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precautions for safe use or exposure. Instruction shall include, as a 
minimum, all information in Appendix IV which is applicable to the specific 
arsenic containing product or material to which there is exposure. The 
Information shall be posted in the work area and kept on file and readily 
accessible to the worker at all places of employment where arsenic is 
involved in unit processes and operations.
A continuing educational program shall be instituted to ensure that 
all workers have current knowledge of job hazards, proper maintenance 
procedures and cleanup methods, and that they know how to correctly use 
respiratory protective equipment and protective clothing.
Information as required shall be recorded on US Department of Labor 
Form OSHA-20 "Material Safety Data Sheet" or a similar form approved by the 
Occupational Safety and Health Administration, US Department of Labor.
Section 6 - Work Practices
(a) Arsenic shall be removed from work areas by vacuum cleaning 
or wet methods, Cleaning may be performed by washing down with a hose, 
provided that a fine spray of water has first been laid down. Sweeping or 
other methods which can stir the dust into the air shall not be used,
(b) Waste material shall be disposed of in a manner which will 
prevent exposure of humans and animals as well as air and water pollution.
(c) Arsenic trichloride shall be handled only in enclosed systems 
sufficient to prevent skin contact and to prevent worker exposure in excess 
of the environmental standard.
(d) Where there is possibility of arsenic trichloride contact with 
the skin, emergency showers shall be provided in readily accessible 
locations. Eye-wash facilities shall also be conveniently located.
(e) Procedures for emergencies, including fire fighting, shall be
established to meet foreseeable events. Necessary emergency equipment,
including appropriate respiratory protective devices, shall be kept in 
readily accessible locations. Only self-contained breathing apparatus with 
positive pressure in the facepiece shall be used for fire fighting. 
Appropriate respirators should also be available for use during evacuation.
(f) Exhaust ventilation and enclosure of processes shall be used 
wherever practicable to control workplace concentrations.
(g) Air from the exhaust ventilation system shall not be recircu­
lated into work areas, and necessary measures shall be taken to ensure that 
discharge outdoors will not produce a health hazard to humans or animals.
(h) Due to potential skin irritation associated with respirator 
use and arsenic dust exposure, workmen shall be permitted to leave the work 
area every two hours to wash their face and obtain a clean respirator.
Section 7 - Sanitation Practices
(a) Employees exposed to arsenic shall be provided with separate 
lockers or other storage facilities for street clothes and for work 
clothes,
(b) Employees exposed to arsenic shall not wear work clothing away 
from the plant.
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(c) Facilities for shower baths shall be provided for employees 
exposed to arsenic. Workers shall bathe before changing into street 
clothes.
(d) Employees exposed to arsenic shall wash before eating or 
smoking during the work shift.
(e) No food shall be permitted in areas where arsenic is handled, 
processed, or stored.
(f) Employees shall not smoke in areas where arsenic is handled, 
processed, or stored.
Section 8 ~ Monitoring and Recordkeeping Requirements
Workroom areas shall not be considered to have arsenic exposure if 
environmental levels, as determined on the basis of an industrial hygiene 
survey or by the judgment of a compliance officer, do not exceed 0.01 mg 
As/cu m. Records of these surveys, including the basis for concluding that 
air levels are below 0.01 mg As/cu m, shall be maintained until a new 
survey is conducted. Surveys shall be repeated when any process change 
indicates a need for réévaluation or at the discretion of the compliance 
officer. Requirements set forth below apply to areas in which there is 
arsenic exposure.
Employers shall maintain records of environmental exposures to 
arsenic based upon the following sampling and recording schedules:
(a) In all monitoring, samples representative of the exposure in
the breathing zone of employees shall be collected. An adequate number of 
samples shall be collected to permit construction of a time-weighted
10
average (TWA) exposure for every operation or process. The minimum number 
of representative TWA determinations for an operation or process shall, be 
based on the number of workers exposed as provided in Table 1-2.
(b) The first environmental sampling shall be completed within 6 
months of the promulgation of a standard incorporating these 
recommendations.
(c) Environmental samples shall be taken within 30 days after 




50% of the number 
of workers
21-100 10 TWAs plus 25%
of the excess over 
20 workers
over 100 30 TWAs plus 5%
of the excess over 
100 workers
Number of Employees Exposed 
1-20
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(d) Samples shall be collected at least bimonthly (every 60 days)
in accordance with Appendix I for the evaluation of the work environment 
with respect to the recommended standard.
(e) Environmental monitoring of an operation or process shall be
repeated at 15-day intervals when the arsenic concentration has been found 
to exceed the recommended environmental standard. In such cases, suitable 
controls shall be initiated and monitoring shall continue at 15-day 
intervals until two consecutive surveys indicate the adequacy of these 
controls.
(f) Records of all sampling and of medical examinations shall be
maintained for at least 20 years after the individual's employment is 
terminated. Records shall indicate the type of personal protective 
devices, if any, in use at the time of sampling. Records shall be 
maintained so that they can be classified by employee. Each employee shall 
be able to obtain information on his own environmental exposure.
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II. INTRODUCTION
This report presents the criteria and the recommended standard based 
thereon which were prepared to meet the need for preventing occupational 
diseases arising from exposure to arsenic and its inorganic compounds other 
than arsine and lead arsenate. The criteria document fulfills the 
responsibility of the Secretary of Health, Education, and Welfare, under 
Section 20(a)(3) of the Occupational Safety and Health Act of 1970 to 
"...develop criteria dealing with toxic materials and harmful physical 
agents and substances which will describe...exposure levels at which no 
employee will suffer impaired health or functional capacities or diminished 
life expectancy as a result of his work experience.M
The National Institute for Occupational Safety and Health (NIOSH), 
after a review of data and consultation with others, formalized a system 
for the development of criteria upon which standards can be established to 
protect the health of workers from exposure to hazardous chemical and 
physical agents.
These criteria for a standard for arsenic and its inorganic compounds 
other than arsine and lead arsenate are in a continuing series of criteria 
developed by NIOSH. The proposed standard applies only to the processing, 
manufacture, and use of arsenical products as applicable under the 
Occupational Safety and Health Act of 1970. Arsine (AsH3) is not included 
in this standard since its toxicity is, markedly different, as are the 
nature and occurrence of occupational exposures to it and the types of 
control measures required. Including lead arsenate in this standard would, 
in effect, increase the allowable concentration since the current Federal
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standard of 0.15 mg Pb3(As04)2/cu m is approximately equivalent to 0.026 mg 
As/cu m. Furthermore, this compound poses the double threat of lead 
poisoning as well as arsenic intoxication and is therefore best considered 
separately.
The standard was not designed for the population-at-large, and any 
extrapolation beyond general occupational exposures is not warranted. It 
is intended to (1) protect against injury from inorganic arsenicals, (2) be 
measurable by techniques that are valid, reproducible, and available to 
industry and official agencies, and (3) be attainable with existing 
technology,
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III. BIOLOGIC EFFECTS OF EXPOSURE
Extent of Exposure
Arsenic is between germanium and selenium in the Periodic Table and 
as a member of Group V its physicochemical properties resemble those of 
phosphorus. [1,2] Its principal valences are three and five, and it is 
ubiquitous, [1,3] being found in small amounts in soils and waters 
throughout the world, as well as in foods, particularly seafood. [1,4] 
Arsenic is a constituent of a number of minerals. For industrial and 
commercial uses, it is obtained primarily from the ores of metals in which 
it is present as an impurity, [5] removed as arsenic trioxide (arsenic 
(III) oxide, As203) during the smelting operation. This oxide is used in 
the manufacture of most other arsenic compounds, and is produced in the US 
as a byproduct in the smelting of copper ores. [6] Physical and chemical 
properties of arsenic and some of its more important inorganic compounds 
are given in Table XI-1. [5,7]
Consumption of arsenic trioxide in the United States is estimated to 
range between 25,000 and 35,000 tons annually. Of this amount, 6,000 to
14,000 tons are produced in the United States. [8] Various arsenic 
compounds are used as pesticides. [1,3,5] Arsenic compounds are also used 
in pigment production, the manufacture of glass, textile printing, tanning, 
taxidermy, in antifouling paints, and to control sludge formation in 
lubricating oils. Metallic arsenic is used as an alloying agent to harden 
lead shot, and in lead-based materials. It is also alloyed with copper to 
improve its toughness and corrosion resistance. [3,6,9]
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Some occupations which have or in the past have had potential 
exposures to arsenic are listed in Table XI-2. [9] NIOSH estimates that
1,500,000 workers are potentially exposed to inorganic arsenic,
Historical Reports
According to Vallee et al, [6] Dr, J. Ayrton Paris reported in 1820 
that exposure to the arsenical fumes from the copper smelters of Cornwall 
and Wales occasionally resulted in cancer of the scrotum, Neubauer [10] 
reviewed the history of the high mortality due to "mountain disease" among 
cobalt miners in Schneeberg and Joachimstal in Saxony, and credited Harting 
and Hesse [11] with first identifying the condition as lung cancer.. 
According to Neubauer, [10] arsenic was first believed to be the carcino­
gen. He concluded that was not the case since Harting and Hesse did not 
report typical signs of arsenicalism (hyperpigmentation, keratoses, etc). 
In his opinion, the etiologic factor was ionizing radiation in the mines.
The significantly increased risk [12] of cancer both of the ethmoidal 
sinuses and of the lung experienced by workers refining nickel by the 
nickel carbonyl process in Swansea, South Wales, was attributed to arsenic 
present as an impurity in the sulfuric acid used prior to 1924. [13,14]
Goldblatt [15] has suggested that finely divided nickel formed by 
decomposition of the gaseous carbonyl and deposited in the lung or on the 
mucosa of the sinuses was responsible. Hueper [16] has demonstrated the 
carcinogenicity of powdered metallic nickel when inhaled for prolonged 
periods by guinea pigs and rats.
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Kelynack et al [17] in 1900 reported an outbreak in Manchester and 
the adjoining areas of Lancashire and Staffordshire, England, of arsenic 
poisoning traced to arsenic-contaminated beer. Peripheral neuritis, 
initially thought to be "alcoholic peripheral neuritis," was the salient 
clinical manifestation. Ataxia, weakness, and sensations of "pins and 
needles" in the limbs were commonly observed. Patients generally had 
watery eyes, sometimes with distinct puffiness about the eyelids. In 
almost all cases a dusky, irregular pigmentation of the skin developed. 
Pigmentation was reportedly most marked on exposed parts, over pressure 
areas, and in the * normally pigmented areas. Frost [2] reviewed the 
incident, including reports that selenium was also found in the beer. 
Tabulating symptoms described in a number of original reports and review 
articles between 1901 and 1943, he concluded that the incident was not
likely due to arsenic alone, since not all symptoms reported in the papers 
he reviewed could be explained solely by arsenic toxicity, but were
consistent with selenium poisoning.
Transverse white striae in the nails (Mee’s lines) were first
described in 1919 [18] as resulting from the ingestion of a large quantity 
of arsenic, and were reported to appear approximately two months after
ingestion. Dinman [19] considered Mee's lines to be suggestive but not 
pathognomonic of chronic arsenic poisoning.
According to Buchanan, [20] 18 cases of poisoning due to arsenic
trichloride were reported in Britain from 1915 to 1918. In the 1939 case 
reported by Buchanan, a quantity of liquid arsenic trichloride was spilled 
over the legs of a processman who was wearing a canister-type respirator.
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The splashed region of the skin was drenched thoroughly with water and all 
the clothing removed very soon after the accident. The man was transferred 
to a hospital within 15 minutes, where he was found to be suffering from 
burns on both legs, conjunctivitis, and throat irritation. Despite the 
fact that he had been wearing a respirator, the man stated he had inhaled 
an irritating gas (a companion, also wearing a respirator, was unaffected). 
The throat irritation became worse and laryngitis developed, followed by 
bronchopneumonia resulting in death 5 days after the accident. Autopsy 
revealed redness and congestion of larynx, trachea, and bronchial mucosae, 
red hepatization of the lower lobes of both lungs, and marked fatty 
degeneration of the liver. The liver was found to contain 3.0 ppm of 
arsenic trioxide, the hair 3.0 ppm, and the urine present in the bladder 
3.5 ppm. Buchanan reported [20] that, in the opinion of the analyst making 
these estimations, the higher liver content five days after the accident 
indicated absorption over a period of time, probably through the skin, 
while the presence of arsenic in the hair suggested previous absorption.
Another fatality was reported by Delepine [21] after arsenic 
trichloride was spilled on one leg of a worker. After death, arsenic was 
found in high concentrations in all tissues examined (lung, liver, kidney, 
pancreas, stomach, heart, and blood), and it appeared that the trichloride 
had been inhaled as well as absorbed through the skin. The heart, liver, 
kidney, pancreas, and stomach were in a state of acute granulo-fatty 
degeneration. The direct cause of death was kidney failure, but the damage 
to the lungs, liver, pancreas, and heart also would have been fatal more or 
less rapidly.
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In 1945, Watrous and McCaughey [22] reported on conditions in a 
pharmaceutical plant manufacturing arsphenamine and related compounds from 
the basic intermediate arsanilic acid, so that exposures in this plant were 
to organic arsenicals. In the manufacturing department, exposures varied 
from 0.02 to 0.60 mg As203/cu m (approximately 0.015 to 0.456 mg As/cu m) 
with an overall average of 0.17 mg As203/cu m (0,129 mg As/cu m). In the 
packaging division, air concentrations ranged from 0.007 to 0.28 mg
As203/cu m (0.005 to 0.213 mg As/cu m) with a mean of 0.065 mg As203/cu m
(0.049 mg As/cu m).
Medical records dating from 1939 were available and were reviewed 
[22] for 35 workers in the manufacturing department, 31 workers in the 
packaging department, and a control group of 30 in a packaging department 
with no arsenic exposure. Records were examined and the number of visits 
to the medical department were tabulated for 5 types of complaints 
considered to be possible indicators of subclinical or borderline 
arsenicalism. These symptoms were: hyperkeratosis, including warts and
cracking, chapped, dry, or thickened skin; gastrointestinal, including 
upset stomach, nausea, vomiting, abdominal pain, loss of appetite, etc; 
central nervous system, such as headache, dizziness, fainting, etc; optic 
nerve, such as blurring or diminution of vision, spots before the eyes, etc 
(there were no complaints of this type in any of the 3 groups); and 
peripheral neuropathy, including shooting pains in the extremities, 
numbness, tingling, or sudden loss of muscular power.
The overall total number of visits per person per year was markedly
higher in the packaging group (21.2) than in the manufacturing (9.6) or
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control group (10.0). [22] The packaging department employees also had a 
significantly higher number of visits per person per year for peripheral 
neuritis complaints (0.13 compared to 0.05 and 0.02). The authors 
concluded that these differences were probably due to an unusual number of 
neurotic individuals in the packaging division since some records contained 
"page after page of vague and bizarre complaints unexplained by any 
physical finding." Both the manufacturing and packaging groups had a lower 
number of visits per person per year for gastrointestinal (0.32 and 0.69) 
and central nervous system (0.22 and 0.19) complaints than did the control 
group (0.83 for GI and 0,76 for CNS complaints). However, both exposed 
groups also had significantly more complaints of hyperkeratosis (0.23 and 
0.20 compared to 0.09).
In the manufacturing department, complete blood counts were made at 
3-month intervals throughout an individual's employment. [22] For the 35 
employees exposed to arsenic, 323 counts were available. From those 
workers in the manufacturing department who performed similar tasks but 
with no arsenic exposure, a control group was randomly selected, providing 
a total of 221 complete blood counts. There was no significant difference 
in white, red, neutrophil, or eosinophil counts or in hemoglobin values.
Effects on Humans
According to Frost [2] in his review of arsenic in biology, inorganic 
arsenicals are more toxic than the organic, and trivalent is more toxic 
than pentavalent arsenic, but he also pointed out that for any such 
generalization exceptions can be found. Arsenic is widely distributed
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throughout body tissues, but can be found in the hair and nails months 
after it has disappeared from the urine and feces. [3] Pentavalent arsenic 
is excreted faster than trivalent arsenic, [1,20] and some authorities 
[1,3] state that trivalent arsenic accumulates in the mammalian body, but 
Frost [2] reported rapid excretion of all arsenicals. Schroeder and 
Balassa [1] and Frost [2] stated that arsenicals are oxidized in vivo from 
trivalent to pentavalent, and not reduced from pentavalent to trivalent. 
On the other hand, as an explanation for the toxicity of some pentavalent 
arsenicals, Buchanan [20] suggested that pentavalent arsenic is slowly 
reduced to trivalent.
The presence of arsenic was illustrated by Schroeder and Balassa [1] 
in a variety of foods purchased in food stores. Mean arsenic values, in ug 
As/g wet weight were: fish and seafood, 4.64; meats, 0.49; vegetables and
grains, 0.41. The highest arsenic levels found were 15.3 ug As/g in shrimp 
shells and 8.86 ug As/g in kingfish. Other high levels were 2.71 in table 
salt, 1.6 in puffed rice, 1.4 and 1.07 in two samples of pork liver, and
1.3 in stewing beef. No arsenic was detected in pork kidney, chicken 
breast, egg lecithin, corn oil, and other items. No arsenic was found in 
the kidneys of 8 wild mice, but the livers and hearts contained 0.74 and 
1.10 yg As/g wet weight. Arsenic was found in the urine of 2 humans in 
concentrations of 0.14 and 0.10 pg As/g of urine (approximately 0.143 and 
0.102 mg As/liter, using a specific gravity of 1.024 for conversion). In 
the hair of 7 humans, the arsenic level ranged from 0.12 in a 3-year-old to 
1.1 Ug As/g of hair in an 80-year-old, with a mean of 0.536 yg As/g. 
Webster [23] also reported the urinary arsenic level of persons with no
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known exposure to arsenic. First morning specimens from 26 adults and 17 
children contained 0.015 and 0,014 mg As/liter of urine, respectively. The 
overall average was 0.014 mg As/liter.
Schrenk and Schreibeis [4] collected 756 urine specimens from 29 
persons with no known arsenic exposure. The average urinary excretion was 
0.08 mg As/liter, with 79% of the samples below 0,1 mg As/liter. The three 
highest levels reported were 2,0, 1.1, and 0,42 mg As/liter, and were 
attributed to probable consumption of seafood. The two highest average 
urinary excretions by individuals were 0.22 and 0.12 mg As/liter,
These authors considered [4] seafood to be the main source of dietary 
arsenic. Shellfish in particular elevated the arsenic of test subjects. 
In one test, three subjects with pretest levels of 0.01, 0.05, and 0.03 mg 
As/liter were given lobster tail for lunch. Four hours after eating, 
urinary levels were 1.68, 1.40, and 0,78 mg As/liter, respectively, but 
after 48 hours, values were approaching the pretest levels.
The excretion by humans of inhaled arsenic was studied experimentally 
by Holland et al, [24] Eight terminal lung cancer patients inhaled smoke 
from a cigarette contaminated with As-74, and 3 others inhaled an As~74 
aerosol from an intermittent positive pressure machine. Uptake and distri­
bution was determined by examining the chest with a radiation counter. The 
radioactive arsenic disappeared from the respiratory tract very rapidly 
during the first few days, falling by the forth day to 20%-30% of the 
original uptake. Thereafter, the rate of disappearance tapered off slowly. 
Approximately 28% of the absorbed As-74 was excreted in the urine the first 
day. By the end of 10 days, urinary and fecal excretion of the absorbed
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As-74 was approaching zero, with 45% having been excreted in the urine and 
2.5% in the feces. The remainder was assumed to have been deposited in the 
body, exhaled, or eliminated over a long time period. Deposition in hair, 
skin, and nails or in organs such as the liver was not reported.
The typical symptoms of severe chronic arsenicalism were illustrated 
in a case history reported by McCutchen and Utterback. [25] The first 
symptoms were an attack of nausea, vomiting, diarrhea, hot flashes, and 
progressive anxiety. These symptoms gradually cleared over a period of 10 
days. Similar episodes continued intermittently. Within the next 2 years 
there was a gradual darkening of the skin, and a thickening and scaling of 
the skin on the soles of the feet, An almost constant pain and feeling of 
"pins and needles" appeared first in the feet and later in the hands. 
Muscular weakness became more apparent and the extremities became numb in a 
glove and stocking distribution. Three years after the first symptoms, the 
skin of the trunk had darkened markedly, there had been a gradual loss of 
vision, and increased pain. Attacks of the initial symptoms continued to 
occur 3 to 4 times annually for 10 years, until the patient was referred to 
specialists for management of severe heart failure and muscular dystrophy. 
At that time, ascites was evident and severe ankle edema had developed. 
The patient was constipated except during the episodes of nausea and 
vomiting, when he had diarrhea. He was emaciated and had a diffuse tan 
pigmentation over the trunk. The palmar and plantar surfaces were 
hyperkeratotic and Mees lines were present on the nails. There was an 
erythematous macular-papular rash below the knees, with indolent, shallow 
ulcers up to 1 cm in diameter. All sensory functions were diminished in a
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diffuse peripheral nerve distribution with a definite increase in 
perception from distal to proximal. The patient could not walk.
Laboratory tests revealed [25] that urinary excretion was 0.140 mg/24 
hours and that the hair contained 20.7 mg As/100 g of hair. The white 
count was low (2,174) with a slight increase in monocytes. Both the EEG 
and ECG were normal. In an effort to increase urinary excretion of 
arsenic, 2,3-dimercaptopropanol (British Anti-Lewisite, BAL) was 
administered but failed to increase arsenic excretion. After 3 months of 
hospitalization, functional use of the hands returned and the patient could 
walk with the aid of leg braces and crutches, Urinary arsenic excretion 
was approximately 0.040 mg/24 hours. A follow-up at 1 year revealed
little, if any, improvement in the neuropathy. Deep tendon reflexes were 
still absent and there was no proprioception distal to the knees or elbows. 
Pigmentation was marked but the dermatitis had cleared completely.
At one time, arsenic was considered a beneficial stimulant to the 
erythropoetic system and was popular as a tonic. [1,26] More recently, 
Kyle and Pease [27] have shown hematologic abnormalities in association 
with chronic arsenic intoxication of 6 patients, Nausea, vomiting, 
diarrhea, and peripheral neuropathy were present in all cases. In 3 cases 
there was pigmentation, and in 3 cases there was hyperkeratosis of the 
palms and soles. However, in 2 cases neither hyperpigmentation nor 
hyperkeratoses were observed. Average urinary arsenic excretion was 1.87 
mg As/liter, with a range of 0.348 to 3.46 mg As/liter of urine. Arsenic 
in the hair averaged 4.88 mg As/100 g of hair, ranging from 1.76 to 8,5 mg
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As/100 g of hair. The nails contained an average of 9.12 mg As/100 g of 
nails, with a range of 0.0 to 42.0 mg As/100 g of nails.
In all 6 cases anemia and leukopenia were present, with thrombo­
cytopenia in 3 cases. [27] White counts of less than 1000 were seen in 3 
cases, with the major change an absolute neutropenia. All patients had 
relative eosinophilia, but the absolute eosenophil count was elevated in 
only one case. Basophilic stippling was a prominent finding. The bone 
marrow of 4 patients was examined, and in 3 of these increased, disturbed 
erythropoiesis was observed. Depressed or disturbed myelopoiesis was seen 
in all four. Hematologic abnormalities disappeared within 2 to 3 weeks 
after cessation of arsenic ingestion.
Butzengeiger [28] examined 180 vinedressers and cellarmen with
symptoms of chronic arsenic intoxication and reported that in 41 (22.8%)
there was evidence of vascular disorders in the extremities. Arsenical 
insecticides were used in the vineyards and workers reportedly were exposed 
not only when spraying but also by inhaling arsenic-contaminated dusts and 
plant debris when working in the vineyards. The homemade wine consumed by 
most of the workers was believed to be contaminated with arsenic.
Fifteen cases were described in detail. [28] All had varying degrees 
of hyperpigmentation and all but 2 had palmar and plantar keratoses. Cold 
hands or feet or both were common to all and apparently preceded the 
development of gangrene on the toes or fingers in 6 of the 15 cases. Liver 
damage was reported in 9 of the 15 cases, but most of the workers consumed 
up to 2 liters of wine daily. Urinary arsenic levels were given in terms
of arsenic trioxide either per liter or per 100 grams of urine. Converting
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all to milligrams of arsenic per liter of urine (assuming a specific 
gravity of 1.024), values ranged from 0.076 to 0.934 mg As/liter, with an 
average of 0.324 mg As/liter. Arsenic in hair ranged from 0.012 to 0.1 mg 
As203/100 g of hair (0.009 to 0.076 mg As/100 g) with an average of 0.051 
mg As203/100 g (0.039 mg As/100 g).
In 1943 Zettel [29] observed 170 soldiers who had been chronically 
exposed to arsenic in their drinking water. Arsenic was demonstrated in 
the hair and nails, but the levels were not reported. Most patients had a 
feeling of weakness, lassitude, dizzy spells, and were easily fatigued. In 
many cases complaints developed of numbness and "pins and needles" in the 
limbs, and of cold hands and feet. In about 120 cases the systolic blood 
pressure at rest was less than 110 mm Hg. Electrocardiograms were prepared
for 80 patients, 45 of whom displayed a broadened Q-R-S interval. The Q-T
was almost always prolonged and, frequently, there was an S-T depression 
and flattening of the T-wave. Six to eight weeks after the first 
examination, repeat ECGs were obtained in 47 cases. The Q-R-S broadening 
initially observed was absent or reduced, and the S-T depression and 
flattened T-wave were observed less frequently.
Butzengeiger [30] reported that, of 192 ECGs from vinegrowers 
suffering chronic arsenic intoxication, 107 (55.7%) were normal, 30 (15.6%) 
showed slight changes which alone were insufficient for a definite 
diagnosis of cardiac damage, and that 55 (28.7%) revealed definite changes. 
Of the 55 with definite changes, in 19 cases the possibility existed of 
causes such as age, arteriosclerosis, or disease. In the remaining 36
cases, no possible causes other than arsenic poisoning were detected. ECG
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abnormalities included Q-T prolongation and flattened T-wave. Follow-up 
studies revealed a decline in ECG abnormalities along with the attenuation 
of other symptoms of arsenic intoxication.
More recently, Barry and Herndon [31] described characteristic 
electrocardiographic changes of nonspecific T-wave inversion and pro­
longation of the Q-Tc interval. In the 3 cases reported, the changes were 
present on initial ECG’s taken shortly after arsenic ingestion at a time 
when no significant alterations in serum electrolytes, serum chemistries, 
neurologic or respiratory systems were present. In one case, ECG had been 
performed 3 months before arsenic was ingested and was normal. This 
patient, a 21-year-old male, died and post-mortem examination showed 
"subendocardial hemorrhage and fibrosis with subepicardial petechiae and 
myocardial perivascular mononuclear infiltration." The ECG changes in the 
remaining 2 patients regressed coincidentally with clinical recovery, 
suggesting to the authors an "acute pharmacologic cardiac insult."
Prolongation of the Q-T interval and an abnormal T-wave was reported 
in 2 cases of chronic and 1 case of acute arsenic intoxication by Glazener 
et al. [32] The ECG changes could not be related to disturbances in serum 
electrolytes and were considered due to a toxic effect on the myocardium. 
In the acute case, approximately 24 hours after arsenic was ingested, the 
serum arsenic level was 0.0173 mg As/100 ml and the urinary level was 1.40 
mg As/liter. Seventeen days after the arsenic was ingested, none could be 
detected in the serum but the urinary level was 0.5 mg As/liter. In the 
chronic cases, arsenic levels were: 0.060 and 0.059 mg As/100 g of hair;
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1.92 and 2.61 mg As/100 g of nails; and, in the urine, 0.30 and 0.124 mg 
As/24 hours, respectively.
Franklin et al [33] observed 3 cases of portal cirrhosis which they 
attributed to prolonged use of Fowler's solution (potassium arsenite). One 
patient had taken Fowler's solution for 2 years for leukemia. The other 
patients had taken the medication for 2 and 6 years, respectively, for 
dermatologic conditions. All had generalized mottling and bronzing of the 
skin, palmar and plantar hyperkeratoses, ascites, and marked ankle edema. 
Portal cirrhosis was diagnosed in all 3 cases and confirmed in 1 case by 
biopsy. There was no history of alcoholism in these cases. Urinary 
arsenic was elevated in only 1 case at 1.68 mg As/liter. The urinary 
levels in the remaining 2 cases were said to be normal, these investigators 
considering 0.0 to 0.06 mg As/liter as normal.
Graham et al [34] determined the arsenic contained in lesions of 
Bowen's disease (an intra-epidermal carcinoma [35]) in 50 patients and in 
the adjacent skin of 30 of these. For comparison, material was examined 
from 119 patients with skin lesions which included basal-cell carcinoma, 
senile keratosis, intra-epidermal epithelioma of Jadassohn, extramatnmary 
Paget's disease, seborrheic keratosis, and others. There was no known 
history of arsenic intake in 95% of the Bowen's disease and control 
patients. The normal level of arsenic was considered to.be 1.0 pg As/g wet 
tissue or less. In the control group, arsenic in lesions and adjacent skin 
was "normal" in 71% of the patients. The arsenic level was "normal" in 
only 18% of the Bowen's disease patients. Statistically, this increased 
arsenic content in Bowen's lesions was highly significant. These arsenical
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keratoses were considered "practically indistinguishable from those of 
Bowen's disease" on a clinical and histological basis. Because of the 
increased concentration of arsenic in Bowen’s lesions, the authors 
suggested arsenic as one of the causes of Bowen's disease,
Twenty-seven cases of multiple cancers of the skin and internal 
organs were reported by Sommers and McManus. [36] Arsenic was considered 
the etiological agent because in all cases but one the patients exhibited 
multiple keratoses of the palms and soles. In the one case without 
keratoses, the patient had been treated for psoriasis with Fowler's 
solution. Overall, 20 patients had some history of medical treatment with 
arsenicals, though very brief in some cases. Two of these also had 
possible occupational exposure. Two other patients without history of 
medical exposure were considered occupationally exposed— a chemist who had 
analyzed sprayed fruit for arsenic and who used arsenic as a gardener, and 
a farmer who used Paris green and lead sprays. Two patients were con­
sidered as possibly exposed occupationally— -an electric welder and a mill 
overseer. Three patients had no known arsenic exposure. Skin was the most 
common cancer site, but carcinomas were seen in the urogenital, oral, 
esophageal, and respiratory epithelium. Ten patients had multiple skin and 
visceral cancers. The remaining 17 had multiple skin cancers.
Epidemiologic Studies
Holmqvist [37] reported an extensive study of dermatitis problems in 
a Swedish copper smelter. Workers reported symptoms of burning and 
itching. The dermatitis was broadly classified into two types: eczematous
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type, with erythema, swelling, and papules or vesicles; and a follicular 
type, with erythema and follicular swelling or follicular pustules. The 
dermatitis was primarily localized on the most heavily exposed areas such 
as the face, back of the neck, throat, forearms, wrists, and hands. 
However, it also occurred on the scrotum, the inner surfaces of the thighs, 
the upper chest and back, the lower legs, and around the ankles. Once 
established, dermatitis continued as long a3 arsenic exposure continued. 
To permit the condition to clear up, sick leave was granted. The average 
length of sick leave required was 13.6 days for initial occurrences and 
10.2 days for recurrences. Hyperpigmentation and keratoses were not 
reported.
Patch tests demonstrated that the dermatitis was due to arsenic, not 
to impurities present in the crude arsenic trioxide. [37] Tests with 
arsenic trioxide and pentoxide, sodium arsenite, and sodium, calcium, and 
lead arsenate demonstrated that all produced dermatitis. Many workers had 
been sensitized to both trivalent and pentavalent arsenic. However, 
Holmqvist also recommended that workers with mild dermatitis, especially 
new employees, continue work since this often resulted in hyposensitivity. 
The incidence of dermatitis was highest in those areas in which arsenic* 
exposure was highest, but occurred in all areas, possibly in sensitized 
individuals where arsenic exposures were low. Dermatitis also was worse in 
the summer months, possibly because workers sweat more than in the winter.
An outbreak of arsenical dermatoses was reported by Birmingham et al
[38] which involved cases in the community outside the plant. A reactiva­
ted gold mine began smelting ore which contained large amounts of sulfides
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of arsenic. It was estimated that 40 tons of arsenic and 100 tons of 
sulfur dioxide were burned off daily, but the dust-collecting system failed 
to operate at the expected 90% efficiency. Within a few months after oper­
ations began, children attending elementary school in the nearby mining 
camp community developed skin lesions, mostly on the exposed parts of the 
body, Thirty-two of the 40 elementary school students had one or more 
types of suspect arsenical dermatoses including eczematous contact dermati­
tis, folliculitis, furunculosis, pyodermas, and ulcerations. Conjunctiv­
itis and rhinitis were common. The eczematous dermatitis was pruritic, 
usually involving the face and flexures, and was highly suggestive of 
atopic dermatitis. The follicular and pustular lesions were mostly on the 
face and neck, although some were on the extremities. Ulcerations were 
seen on the palms, fingers, toes, and webs. The high school students who 
spent 10 to 12 hours a day away from the community did not have dermatitis. 
Nine of eighteen mill workers on the day shift had similar skin lesions. 
Two also had ulcerations and perforations of the nasal septum. The urinary 
arsenic levels of elementary school children and smelter workers reportedly 
"compared favorably'1 with 0.82 mg As/liter reported by Pinto and McGill
[39] for copper smelter workers exposed to arsenic. One urinary arsenic 
value was elevated, at 2.06 mg/liter, in an ore roaster worker.
The mortality experience in an English factory manufacturing a sodium 
arsenite sheep~dip was reported in 1948 by Hill and Faning, [40] Death 
registers were consulted for the town in which the factory was located and 
for a nearby town in which there was a hospital. Records indicated that, 
between 1910 and 1943, there were 75 deaths of factory workers and 1,412
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deaths of other workers who were residents of the factory town. This lat­
ter group was subdivided by occupation into four groups: 319 agricultural
workers, 701 skilled artisans or shop workers, 196 general laborers, and
196 other workers, in mainly professional, managerial, and clerical occupa­
tions. This last group was not used for comparison purposes, since it was
not considered comparable on a social and industrial basis. Excluding that
group left 1,216 deaths in the other 3 groups, with cancer deaths
representing 14.4%, 13.8%, and 12.0%, respectively, or 12.9% overall.
The cancer deaths were classified into 6 broad site groups. There 
was no apparent difference between the factory workers and the other 3 
occupational groups with respect to cancer of the buccal cavity and 
pharynx, genitourinary organs, and other or unspecified sites. However, 
there was an apparent excess among factory workers of deaths due to cancer 
of respiratory system (31.8% compared to 15.9%) and of the skin (13.6% 
compared to 1.3%), with a corresponding deficit in deaths due to cancer of 
the digestive organs and peritoneum (22.7% compared to 58.0%).
Based on factory records and the advice of factory personnel, the 
deaths among factory workers were subdivided [40] according to the 
occupations within the factory. Three groups resulted: chemical workers,
engineers and packers, and a general group including builders, printers, 
watchmen, carters, boxmakers, etc. Of 24 deaths in this last group, 3 
(12.5%) were due to cancer, an incidence very similar to that observed in
the 3 nonfactory groups. Sixteen of 41 deaths (39.0%) among chemical
workers and 3 of 10 deaths (30.0%) among engineers and packers were due to
cancer. Statistically, the cancer incidence in the engineers and packers
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group did not differ significantly from the control group, but the cancer
mortality of the chemical workers was significantly higher (P = 0,047). 
All lung cancer and skin cancer deaths (5 and 3, respectively) recorded 
among factory workers occurred in the chemical worker group.
Perry et al [41] conducted clinical and environmental investigations 
at this sheep-dip factory during 1945 and 1946, On 5 occasions over a 12- 
month period, general room samples were collected in 4 work areas: in the
packing room, drying room, sieving room, and near the kibbler operator. 
Median concentrations were 0,071, 0,254, 0.373, and 0.696 mg As/cu m,
respectively. Arsenic analyses were made on urine and hair samples from 4 
groups of workers: 31 chemical workers, 20 maintenance workers (engineers,
builders, etc), 12 packers, and 56 unexposed controls consisting of office 
workers, men from a printing and bookbinding department, truck drivers, box 
makers, and chemical workers not recently exposed to arsenic. An effort 
was made to collect 24-hour urine samples twice and to collect 2 hair 
samples from each worker. However, not all workers cooperated, so that 
there was a total of 58, 32, 22, and 54 urine measurements and 27, 17, 11, 
and 44 hair samples, respectively, for the four groups. The average 
arsenic excretion was 0.24, 0,10, 0.11, and 0.09 mg As/liter of urine, and 
108, 85, 64, and 13 ppm As in hair, respectively. With regard to arsenic
both in hair and in urine, exposed workers had significantly higher levels
than did the unexposed controls. The three exposed groups did not differ
significantly with respect to arsenic in hair, but the urinary excretion of 
arsenic by chemical workers was significantly higher than the excretion by 
maintenance workers and packers.
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The workers were given a full physical examination with particular 
attention to pigmentation and the number of warts, [41] They were given a 
chest X-ray, a vital capacity test, and an exercise tolerance test. One 
worker showed an enlarged mass at a hilum, but bronchoscopy did not reveal 
a neoplasm. Otherwise, no abnormal results of the X-ray, vital capacity 
tests, or exercise tolerance tests were mentioned. Pigmentation keratoses 
and wart formation were considered quite typical of arsenic exposure, and 
"changes were so evident that the person carrying out the physical 
examination could readily tell whether the man he was examining was a 
chemical worker without asking any questions,” The degree of pigmentation 
was subjectively rated as from one to four plus and the number of warts was
recorded. Nine of the 31 chemical workers examined had from 1 to 6 warts,
and their pigmentation was rated as negative in 3 workers, 1 plus in 10, 2 
plus in 9, 3 plus in 7, and 4 plus in 2. Of 20 maintenance workers and 12 
packers: 1 had 4 warts and pigmentation was rated as negative in 20
workers, 1 plus in 9, and 2 plus in 3. Of the 56 controls, 2 had 1 wart
each and pigmentation was rated as negative in 46 workers, 1 plus in 8, and
2 plus in 2 (both of these were former chemical workers).
Snegireff and Lombard [42] conducted a statistical study of cancer 
mortality in the metallurgical industry. From 1922 to 1949, 146 deaths
were recorded among the employees at one plant (Plant A) handling large 
quantities of arsenic trioxide. No mention is made of methods used to 
trace former and retired employees, so it appears that only deaths among 
active plant employees were considered. Of the 146 deaths recorded, 18 
were due to cancer and 7 of these were ascribed to cancer of the
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respiratory system. The 18 deaths due to all types of cancer represented a 
slightly higher proportionate cancer mortality (12.3 cancer deaths per 100 
deaths) than observed in the state as a whole (10.0 cancer deaths per 100
deaths). A total of 72 deaths were reported among employees under age 55,
and 9 of these were due to cancer of all types (12.5 cancer deaths per 100 
deaths). In contrast, the proportionate cancer mortality for this age 
group in the state as a whole was 6,1 per 100 deaths. The authors showed 
that both of these increases in proportionate cancer mortality were not 
statistically significant.
Also studied was the cancer mortality of Plant Z, comparable to Plant 
A except that no arsenic was handled. [42] In Plant Z from 1941 to 1949, 
12 of 109 deaths were due to cancer of all types (11.0 cancer deaths per
100 deaths), and 6 of the 12 cancer deaths were due to lung cancer.
Compared to the state as a whole in which it was located, (9.6 cancer 
deaths per 100 deaths), Plant Z had a higher proportionate cancer 
mortality, but this was not statistically significant. In the under 55 age 
group, the mortality due to cancer of all types again was higher (8.3 
compared to 5.7 cancer deaths per 100 deaths) in Plant Z, but was not 
statistically significant. On the basis of this evidence, they concluded 
that the handling of arsenic trioxide in industry did not produce 
significant change in the cancer mortality of plant employees.
By examining only deaths among active plant employees, the authors 
failed to consider deaths among former employees, including those who 
retired or changed jobs after long exposure. Therefore, the true cancer 
mortality may have been higher. Furthermore, the authors did not attempt
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to compare respiratory cancer mortality in the plants with that in the 
state as a whole, despite the fact that cancer of the respiratory system in 
Plants A and Z represented 38.9% and 50.0%, respectively, of all cancer 
deaths.
Using the total cancer deaths experienced in each plant, NIOSH 
calculated the expected number of respiratory cancer deaths, by age group, 
that should have occurred if rates for the appropriate US population were 
applied. Mid-years were chosen for Plants A and Z (1938 [86] and 1945,
[87] respectively) for application of the indirect method of standard­
ization. Since data necessary for a reasonably sound evaluation of the 
respiratory cancer deaths were not available, numerous assumptions must be 
made keeping in mind the limitations they impose. Nevertheless, it is 
interesting to show, under these limitations, how the respiratory cancer in 
Plants A and Z compared to the US experience for a similar time period. 
Plant A experienced a 460% excess in respiratory cancer deaths relative to 
mortality from all causes in 1938. The Plant Z excess was somewhat less at 
350%. When respiratory cancer deaths in the plants were compared to all 
cancer deaths, the excess was 450% and 550% in Plants A and Z, respect­
ively, This was in sharp contrast to the total cancer mortality relative 
to all causes of death when using the same control populations for the two 
plants. In this case, the cancer death experience showed deficits for 
Plants A and Z of 4% and 25%, respectively. Thus, even if the absolute 
figures used were inaccurate, the relative difference demonstrated here 
indicates that it was the respiratory cancer that required detailed 
investigation in the original study. A representative control population
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might also have shown an excess and could have indicated problems both in
Plant A and Z. This would then make it inappropriate to compare Plant A to
Plant Z, since Plant Z also demonstrated evidence of some type of
carcinogen for respiratory cancer.
Using unpublished data supplied by Lull and Wallach, Hueper [45] 
reported the cancer mortality in several Montana counties in which copper 
smelters and mines were operated for many years. In three counties in 
which the major industry was copper smelting and/or mining, the annual lung 
cancer death rate per 100,000 male population ranged from 46.3 to 145.7 for 
1947-48, In contrast, a rate of 5.2 per 100,000 was reported for a county 
in which the major industry was agriculture. The estimated [45] lung
cancer death rate among white males in the United States as a whole in 1947 
was 10.9 per 100,000.
Roth [46] reported the results of 47 autopsies of German vinegrowers. 
Autopsies were conducted because the individuals had been chronically 
poisoned by exposure to arsenical insecticides in the vineyards and by 
arsenic contaminated common wine. Cancer was listed as the cause of death 
of 30 of the 47 cases (64%), and malignancies were observed in an addi­
tional 3 cases. A total of 75 malignant tumors (40 of which were skin 
cancers) of various tissues were observed in these 33 cases with malignan­
cies. Lung cancer was listed as the cause of death in 18 cases, liver 
sarcomas in 6 cases, carcinoma of the esophagus in 5 cases, and bile duct 
carcinoma in 1 case. There were 10 cases of multiple tumors of the skin 
and internal organs, and 4 cases of multiple tumors of internal organs.
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"Arsenic cirrhoses" were listed as the cause of death in 8 cases, and were 
observed in an additional 15 cases.
The lung cancer mortality of 6 rural and urban districts of the 
Moselle and 1 district of the Ahr were compared. A statistical treatment 
was not attempted, but Roth [46] reported that, in general, vineyard areas 
of the Moselle had a higher proportionate mortality due to lung cancer than 
did the urban and nonvineyard areas. The vineyard areas of the Ahr also 
had lower incidence of bronchial cancer, which was attributed to the fact 
that arsenical insecticides had never been used there. Roth considered 
that, in combination with his autopsy findings, this strengthened an 
etiological link between the arsenical insecticides and bronchogenic 
carcinoma. He did not consider it appropriate to propose such a link in an 
individual, case unless there was a history of arsenic exposure and unless 
there were symptoms of chronic arsenic poisoning, such as melanosis and 
hyperkeratosis of the skin, single or multiple skin cancers, or peripheral 
disturbances of circulation.
Pinto and McGill [39] studied the effects of arsenic exposure in a 
smelter producing arsenic trioxide as a byproduct. Much qualitative 
information on the plant environment was reported, but no actual air 
measurements were made, and the necessity for protective clothing and 
respirators was stressed. Work clothes used were underwear, socks, and a 
one-piece denim coverall with attached hood for covering the scalp, ears, 
and back of the neck. Dust-tight goggles were recommended to prevent 
conjunctivitis in high dust concentrations. Respirators consisted of a 
hard metal frame holding layers of surgical sheetwadding. These
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respirators were reportedly 99% effective when tested against arsenic 
trioxide dust loadings of 99 to 1740 mg/cu m. No further details of this 
testing were given. Perry et al [41] described very similar respirators 
that were used in the English sheep-dip factory as "masks of cotton wadding 
held in place by a wire frame."
Urinary arsenic levels were reported [39] for exposed and nonexposed 
workers employed in the smelter. In 147 samples from 124 nonexposed 
workers, urinary arsenic levels ranged up to 2.07 mg As/liter in one case
(the second highest sample reported was 0.7 mg As/liter) and the mean was
0.13 mg As/liter. The average of 835 samples from 348 exposed workers was 
0.82 mg As/liter with 7 samples reported as 4.0 mg As/liter or more. There 
is a distinct difference in the two groups, and the urinary level for the 
"nonexposed" workers is consistent with that reported by Watrous and 
McCaughey [22] for 13 job applicants with no known arsenic exposure. 
However, other studies have shown considerably lower normal urinary arsenic 
levels. For example, Schrenk and Schreibeis [4] reported an average of 
0.08 mg As/liter based on 756 specimens from 29 persons with no known 
exposure, Perry et al [41] reported a mean of 0.085 for 54 controls, and 
Webster [23] reported an average of 0.014 mg As/liter based on samples from 
43 adults and children. Furthermore, Milham and Strong [47] measured the 
urinary arsenic levels of residents on a downwind transect from the smelter 
studied by Pinto and McGill, [39] and found arsenic levels decreased with
distance from the smelter. Levels were 0.3 ppm at a distance of 0 to 0.4
miles, and 0.02 ppm at a distance of 2.0 to 2.4 miles. Samples of vacuum 
cleaner dust were also collected, and arsenic was reported to decline from
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1300 ppm at a distance of 0 to 0.4 miles to 70 ppm at a distance of 2.0 to
2.4 miles. This suggests that arsenic exposure was not confined to one 
section of the smelter, but extended also to the surrounding community. 
Thus, the "nonexposed" smelter workers might also have had a degree of 
arsenic exposure.
Effects observed, [39] presumably among the "exposed" workers, were 
dermatitis, perforation of the nasal septum, conjunctivitis, turbinate 
inflammation, and pharyngitis. Blond and reddish skinned persons were 
reported to be more sensitive to the irritating action of arsenic. Some 
cases of dermatitis were attributed to hypersensitivity, The authors 
considered dermatitis to be dependent on the sensitivity of the individual 
and on the degree of skin contact with arsenical dusts. Dust-in-air 
measurements were considered of limited value in predicting skin reactions, 
as were levels of arsenic in urine. However, based on a study of 127 
individuals, the authors reported that dermatitis was observed in 80% of 
those excreting 1,0-3.0 mg As/liter and in 100% of those excreting more 
than 3.0 mg As/liter. No excessive pigmentation or keratoses were seen, 
and all observed effects were considered preventable by faithful use of the 
protective clothing and respirators described,
In a later paper based on the same plant population, Pinto and 
Bennett [48] analyzed the causes of death for a total of 229 active plant 
employees and pensioners. The pensioners were defined as being at least 65 
years of age at the time of the study, and as having had at least 15 years 
service in the plant. The total population at risk is not known since the 
study excluded all workers who left the plant before retirement. Neverthe­
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less, the authors stated that the mortality figures "truly represent the 
causes of death in this plant for the individuals who stay long enough to 
have significant contact with industrial dusts and fumes." The 1958 cause- 
specific proportionate mortality of males aged 15-94 in the same state was 
used for comparison. The age range of the smelter group was 19-95. A 
slight excess of cancer deaths was observed in the smelter group (18.8% of 
all deaths compared to 15,9% in the state as a whole), but the increase was 
not statistically significant. Subdividing cancer deaths by site, the 
smelter group was shown to have an increased incidence of deaths due both 
to cancer of respiratory system (41.9% vs 23.7% of cancer deaths) and of 
the breast and genitourinary tract (18.8% vs 11.6% of cancer deaths). 
There was a decrease in the proportion of deaths due to cancer of the 
digestive organs and peritoneum (18.6% vs 34.5%). The deaths in the 
smelter group were also classified into deaths among ’’exposed“ and 
"nonexposed” workers, revealing that relatively more cancer deaths occurred 
among the "nonexposed" (19.4% of all deaths) than among those "exposed" to 
arsenic (15.8%).
Compared to the data for the state as a whole, the smelter workers 
were also shown [48] to have slightly increased mortality due to cardio­
vascular disease (65,5% of all deaths compared to 59.0% in the state as a 
whole), but the increase was not statistically significant. An excess was 
observed in the 45-64 age bracket for both "exposed" and "nonexposed" 
workers (36.8% and 25.7%, respectively, compared to 15.2% for this age 
group in the state as a whole), with a reduction in cardiovascular 
mortality in the 65-94 age bracket for both groups (31.6% and 36,6%,
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respectively, compared to 41.9% in the state.) Because the cardiovascular 
mortality was similar in both "exposed" and "nonexposed" groups, the 
authors concluded that arsenic exposure had no effect.
The "exposed" and "nonexposed" categories are suspect, however, since 
the urinary arsenic levels reported by Pinto and McGill [39] and cited by 
Pinto and Bennett [48] indicate that the "nonexposed" group did in fact 
have a degree of exposure to arsenic. Consequently, one must also question 
the conclusions that, because the mortality experience was similar in the 
two groups, increases in cardiovascular and cancer mortality are unrelated 
to arsenic exposure. The increase in overall cancer mortality was shown to 
be statistically not significant, but the respiratory cancer mortality in 
the smelter group was 18 of 229 deaths (7.9%) compared to 518 of 13,759 
deaths (3.0%) in the state as a whole. Similarly, overall deaths due to 
cardiovascular disease were increased in the smelter group, but not 
significantly so. The increase, however, was entirely concentrated in the 
45-64 age group (63 deaths compared to 38.52 expected) and was partially 
offset by a decrease in the 65-94 age group (82 deaths compared to 106.54 
expected).
A recent study of mortality among workers at this plant was reported 
by Milham and Strong. [47] In this case, death certificates for the county 
in which the smelter is located were examined. In the years 1950-1971, 39 
deaths due to respiratory cancer were recorded among county residents 
listed as employed at the smelter. Records at the smelter revealed one 
employee who was not a resident of the county but who died of respiratory 
cancer. Since the average annual population at risk (904 active employees
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and 209 pensioners) and their age distribution as published by Pinto and 
Bennett [48] was essentially unchanged, the 1960 age-cause specific 
mortality statistics for white males in the US were applied to compute an 
expected total respiratory cancer mortality of 18. [S Milham, written 
communication, October 1973] The increased respiratory cancer mortality, 
40 observed compared to 18 expected, was statistically significant (P less 
than 0.001).
Lee and Fraumeni [49] conducted a mortality study of 8,047 white male 
smelter workers exposed to arsenic trioxide during 1938 - 1963. The
smelter workers were classified into 5 cohorts based on total years of 
smelter work completed: (1) 15 or more years completed before 1938, (2) 15
or more years completed between 1938 and 1963, (3) 10 to 14 years, (4) 5 to
9 years, (5) 1 to 4 years. No specific environmental data were provided, 
but the smelter workers also were divided occupationally into three 
categories with respect to relative level of arsenic trioxide exposure: 
arsenic kitchen, Cottrell, and arsenic roaster workers were classified as a 
heavy exposure group; converter, reverberatory furnace, ore roaster and 
acid plant, and casting workers as a medium exposure group; and all other 
smelter workers were classified as a light exposure group. According to
Lee and Fraumeni, [49] this classification was made for them by two 
individuals at the Division of Occupational Health, USPHS, based on 
-unpublished data. The data used had been collected in a 1965 survey of one 
US copper smelter and aré presented in Table XI-3. The "heavy," "medium," 
and "light" exposure categories were based on these exposure data and on
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these individuals' experience with the smelting industry. Urinary arsenic 
levels collected in the 1965 survey are listed in Table XI-4.
For comparison, the mortality statistics were used for the white
male population of the states in which the various smelters were situated. 
[49] The total mortality of smelter workers was significantly increased. 
The specific causes of death which were significantly elevated were 
tuberculosis, respiratory cancer, diseases of the heart, and cirrhosis of 
the liver. Respiratory cancer mortality was significantly increased in all
5 cohorts. Mortality due to diseases of the heart was significantly
increased in cohorts 2, 3, 4, and 5. Deaths due to cirrhosis of the liver
were significantly elevated to cohorts 2 and 5, while tuberculosis
mortality was significantly higher only in cohort 5.
When respiratory cancer deaths were grouped according to relative 
level of arsenic exposure, the observed mortality was significantly higher 
than expected in all 3 groups: approximately 6.7, 4.8, and 2.4 times
expected in the heavy, medium, and light exposure groups, respectively. 
[49] In addition to arsenic trioxide, the smelter workers were 
simultaneously exposed to sulfur dioxide in over 5,000 of the cases, to 
silica in an unstated number of cases, to lead fume in 35 cases, and to 
ferromanganese dust in 317 cases. Therefore, a similar classification was 
made for relative sulfur dioxide exposure. Respiratory cancer mortality
was directly related, with observed deaths ranging from 6.0 to 2.6 times 
expected in heavy, medium, and light exposure groups. Most work areas 
having heavy arsenic exposure were also medium sulfur dioxide and all jobs
with heavy sulfur dioxide exposure were medium arsenic areas. It was
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observed that xrorkers with heaviest exposure to arsenic and moderate or 
heaviest sulfur dioxide exposure were most likely to die of respiratory 
cancer. Smoking histories were not available for the workers in this 
study, but the authors discounted smoking as the major factor, concluding 
that "it is highly unlikely that smoking alone would account for the 
excessive respiratory cancer mortality observed.” Furthermore, there was 
no reason to expect that the amount smoked would be related to either the
degree of arsenic or sulfur dioxide exposure.
Animal Toxicity
The acute oral toxicity of arsenic trioxide in mice and rats was 
tested by Harrisson et al [50] using both "crude” or commercial grade 
(97.7% As203 with 1,18% Sb203) and highly purified arsenic trioxide
(99,999+% As203). Solutions were administered intraesophageally using an 
oral feeding tube. Test animals had been previously fasted for 24 hours. 
The acute oral LD50 for young Webster Swiss mice was estimated as 39.9 mg 
As/kg for the purified trioxide and as 42.9 mg As/kg for the commercial
grade. For Sprague Dawley albino rats the LD50 was 15.1 mg As/kg and 23.6
mg As/kg for the pure and crude preparations, respectively. Despite its 
lower LD50, the purified arsenic was found to be less severe as a 
gastrointestinal irritant than was the crude trioxide. Retching during 
life and marked gastrointestinal damage at autopsy were observed only in 
animals receiving the crude arsenic trioxide. This was attributed to the 
antimony in the crude preparation.
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Sharpless and Metzger [51J conducted a series of feeding experiments 
to investigate the relationship between arsenic and iodine. Young rats 
were fed basal diets with arsenic trioxide or pentoxide and potassium 
iodide added in varying ratios. Two control groups received the basal diet 
plus potassium iodide at one of two concentrations. In the one group 
receiving arsenic trioxide and potassium iodide, no effects were observed 
relative to the controls. The authors considered it "probable that 
insufficient arsenic was absorbed to exert either a toxic or goiterogenic 
effect."
In rats receiving nontoxic amounts (0.005% of the diet) of arsenic 
pentoxide, "a slight, but not significant" goiterogenic effect was 
observed. [51] When arsenic was 0.02% of the diet, growth was decreased by 
50% and the authors calculated that the iodine requirement was more than 
doubled. Thyroid weights were significantly increased while the iodine 
concentration in the thyroid decreased, even when iodine was administered 
at 5 times the minimum requirement. The authors suggested [51] that in 
man, arsenic in nontoxic amounts has an insignificant effect, but that in 
areas where the iodine intake is relatively low, a goiterogenic effect 
could be expected if the arsenic intake were sufficient to be slightly 
toxic.
Similarly, Dubois et al [52] reported antagonistic effects between 
arsenic and selenium. Albino rats given sodium arsenite or arsenate either 
in drinking water or in the diet were protected against toxic effects of 
seliniferous wheat, sodium selenite, and selenium-cystine. Arsenic 
sulfides (AsS2 and AsS3) in the diet did not prevent selenium poisoning.
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Arsenic in drinking water was effective if administration began within the 
first 20 days of selenium administration. After 30 days of selenium in the 
diet, arsenic provided no protection.
Ginsburg and Lotspeich [53] investigated the mechanisms of renal 
arsenate excretion in the dog and reported similarities between arsenate 
and phosphate excretion. Net tubular reabsorption of arsenate was 
observed, inhibited by increased plasma phosphate concentrations. The 
authors interpreted this as indicating a competitive interaction between 
these ions. Reduction of arsenate to arsenite was reported, but whether 
this occurred in the urine, either in the lumen of the kidney tubules or in 
the bladder, or intracellularly could not be determined. Ginsburg [54] 
later reported that reduction to arsenite occurred intracellularly. 
Arsenite then diffused across both luminal and antiluminal faces of the 
tubular cell, resulting in higher plasma arsenite levels in renal venous 
than in renal arterial blood.
Byron et al [55] conducted a 2-year feeding study of the effects of 
sodium arsenite and sodium arsenate administered in the food of Osborn- 
Mendell rats and beagle dogs. Weight records were kept, blood samples were 
taken periodically, and animals were autopsied at death. At the end of 2 
years, survivors were killed and autopsied. Many post-mortem tissues were 
preserved for microscopic study.
In rats, marked enlargement of the common bile duct was observed at 
the highest dosage of both compounds (250 and 400 ppm for the arsenite and 
arsenate, respectively). At the next lower dosages of both (125 and 250 
ppm), enlargement was present but less pronounced. Arsenate slightly
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reduced survival and both compounds caused reduced weight. Some changes 
were noted in the hematologic study. None of the dogs on the highest 
arsenite dosage (125 ppm) survived for 2 years, but 5 of 6 on the highest 
arsenate dosage (125 ppm) did survive. In the nonsurvivors, gross and 
microscopic changes were essentially those of inanition. All dogs on the 
high dosages lost much weight, but those at levels of 50 ppm or less did
not differ from controls. No carcinogenic effect of these two arsenicals
could be detected.
Using weanling Long-Evans rats, Schroeder et al [56] evaluated the 
effects of arsenic by feeding diets low in arsenic (0.46 yg As/g wet
weight) and administering sodium arsenite in the drinking water of
experimental animals at a level of 5 Hg As/ml. The experiment continued 
until the natural death of the animals. No specific disorders were 
observed in the control or experimental groups, nor was there a 
carcinogenic or tumorigenic effect. No. arsenical keratoses were observed. 
The growth rates and life spans of the two groups did not differ. However, 
male rats had elevated serum cholesterol levels and lower glucose levels 
than did the controls. Arsenic accumulated with age in all tissues 
analyzed. Levels (pg As/g of wet tissue) in control and experimental rats, 
respectively, were: kidney, 0.0 and 27.63; liver 0.21 and 46.92; heart,
0.53 and 34.53; lung, 0,25 and 46.19; spleen, 0.31 and 39.79.
Rozenshtein [57] conducted an experimental inhalation study using 
albino rats. He was concerned with the effects of atmospheric pollution by 
arsenic trioxide on the community at large, so three groups of female 
albino rats were exposed 24 hours a day for three months to a condensation
aerosol of freshly sublimed arsenic trioxide at levels of 0.06, 0.0049, and 
0.0013 mg As203/cu m (approximately 0.046, 0,004, and 0,001 mg As/cu m). 
The animals were studied biochemically and neurophysiologically during each 
month of exposure and during the recovery period after the termination of 
exposure. Some animals were killed one month after exposure ended and 
tissues were examined histologically and histochemically. The author did 
not state how many animals were involved in the study.
Inhibition of blood cholinesterase activity was detected during the 
exposure and recovery periods only in the high exposure group. In this 
same group, an increase in blood pyruvic acid concentration was detected. 
Free -SH groups in whole blood also were lower and remained low after a 
month’s recovery period. A disturbance of the normal chronaxial ratio of 
antagonistic muscles was seen in the two highest exposure groups, and was 
still apparent one month after exposure in the highest exposure group. 
Some accumulation of arsenic, mostly in the lungs and liver, was shovm at 
the end of the exposure period in the two highest exposure groups. In the 
most heavily exposed animals these organs retained a high arsenic content 
one month after exposure.
Microscopic examination of the brains of animals in the highest 
exposure group showed pericellular edema and plasma-cell infiltration of 
vascular walls, plasmolysis, and karyolysis in addition to shrivelling of 
neurons in the middle pyramidal tract. [57] In the bronchi of these 
animals there was accumulation of leukocytic exudate, and in the liver 
there was fatty degeneration of hepatic cells. There were less marked
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changes in the tissues of the intermediate exposure group. Unexposed 
animals were used as controls for the above observations.
The animals exposed to only 0.0013 mg As203/cu m (0.001 mg As/cu m) 
showed none of the foregoing ill effects. On this basis the author 
proposed [57] 0.001 mg As203/cu m as the "mean diurnal maximum permissible 
concentration of this compound in the atmosphere...." This was apparently 
intended to be a standard for the population-at-large implying 24-hour 
exposure.
Another animal inhalation study with arsenic trioxide which in some 
respects more closely approaches human occupational exposure was conducted 
by Bencko and Symon. [58] In this case hairless mice were used to 
eliminate the possibility of ingesting fur-retained dust during grooming. 
The animals were exposed 6 hours daily, 5 days a week for up to 6 weeks to 
fly ash containing 1% arsenic trioxide. Particle size was less than 10 
microns, and the mean air concentration of arsenic was 0.1794 mg/cu m. 
Mice were killed serially after 1, 2, 4, and 6 weeks of exposure, and the 
liver, kidney, and skin analyzed separately for arsenic content. No micro­
scopic examination of tissues was performed and there was no statement as 
to whether the animals were pathologically affected in any way.
Arsenic levels in liver and kidney peaked at 2 weeks exposure. [58] 
At 4 and 6 weeks arsenic content fell to much lower levels, only slightly 
higher than in nonexposed controls despite continuing exposure. This 
implies that, after an initial latent period, the excretory mechanisms for 
arsenic increase in capacity and maintain an increased level for at least 6 
weeks in the mouse, preventing accumulation of arsenic in liver and kidney.
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In the skin, the arsenic content continued to rise until the fourth week of 
exposure. By the sixth week, the arsenic level had declined by about one- 
third and remained a little higher than at the end of the first week of
exposure. It does not appear that any of the mice died from the effects of
their exposure during the experiments.
These results confirmed an earlier paper by Bencko and Symon [59] in
which they reported studies of arsenic in the skin and liver of hairless
mice given arsenic in their drinking water. Arsenic trioxide was 
administered in a 32-day subchronic experiment and in a 256-day experiment. 
In both experiments, the maximum arsenic content of the skin and liver was 
reached on the 16th day. Thereafter, arsenic values decreased in the skin 
and liver, being particularly manifest in the long-term experiments.
Teratogenic effects have been observed in golden hamsters [60,61] 
and in mice [62] after Injection of pregnant animals with sodium arsenate.
A variety of effects were demonstrated, including anencephaly, renal
agenesis, and rib malformations in the hamster, [61] and exencephaly, 
agnatha, and various skeletal defects such as fused and forked ribs in 
mice. [62] Holmberg et al [60] reported that simultaneous injections of
sodium selenite and sodium arsenate significantly reduced the teratogenic 
effect of sodium arsenate in the golden hamster. This evidence of 
metabolic antagonism between selenium and arsenic is consistent with the 
earlier report [52] that sodium arsenite provided a degree of protection 
against selenium poisoning in rats.
Leitch and Kennaway [63] reported a metastasizing squamous 
epithelioma in 1 of 100 mice receiving 86 twice-daily applications of
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alcoholic 0,12% potassium arsenite on the shaved skin. Leitch [64] was 
unable to reproduce this result on a repetition of the experiment.
Roth reported [46] increased incidence of cancer among German vine­
dressers who apparently ingested a significant amount of arsenic in contam­
inated wine. Using 4 groups each of Bethesda black rats and C57 black 
mice, Hueper and Payne [65] administered arsenic trioxide in drinking water 
and in a 12% aqueous solution of ethyl alcohol. Control groups received 
either pure water or the 12% alcohol solution. The rats tolerated the 
arsenic solutions well and gained weight, but the mice died rather early.
With the exception of leukemia in one mouse receiving pure water, 
there were no cancers in mice, [65] The highest number of cancers in rats 
occurred among those on the alcoholic solution of arsenic, but they did not 
differ in type from those in the control groups. The rats receiving pure 
water had the highest incidence of reticulum cell sarcomas of the liver. 
There was one skin cancer (a squamous cell carcinoma of the cheek) in this 
control group, identical in site and type to the 2 skin cancers observed in 
the principal experimental group, the group receiving arsenic in alcoholic 
solution.
Baroni et al [66] tested both arsenic trioxide and sodium arsenate 
for primary carcinogenic effect, for cancer initiating effect in combina­
tion with the promoter croton oil, and for cancer promoting effect fol­
lowing administration of the carcinogens 7, 12-dimethyl benz(a)anthracene 
and urethan, in mice, The arsenic trioxide was administered as a 0.01% 
solution in the drinking water, and the sodium arsenate was applied to the
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skin of the mice as a 1.58% solution in a 2.5% solution of detergent. The 
results were entirely negative for all three types of effect.
Osswald and Goerttler [67] observed a marked increase in the 
incidence of lymphocytic leukemias and malignant lymphomas in female Swiss 
mice and their offspring following subcutaneous injections of arsenic. 
Injections of a 0.005% aqueous solution of the "sodium salt" (the valence 
of the arsenic was not specified) were given daily during gestation (a
total of 20 injections) in a dose of 0.5 mg As/kg. The leukemia rate was
increased both in the females (11 of 22 deaths due to leukemia) and in 
their offspring (13 of 59 deaths). The leukemia rate was further increased 
when arsenic was injected subcutaneously into the offspring themselves (41 
of 92 deaths). In 20 females receiving 20 once-weekly intravenous 
injections of 0.3 mg As, 11 of 19 deaths were due to leukemia. Among 35
male and 20 female controls, 3 of 20 deaths among the males and none of 16
deaths among the females were due to leukemia.
Correlation of Exposure and Effect
There are no environmental data in the reports by Holmqvist [37] and 
Birmingham et al [38] on the effects of arsenic on the skin, but a dose- 
response relationship is implied in both. Despite sensitization problems, 
Holmqvist [37] reported that the incidence of dermatitis was highest in 
areas with heaviest arsenic exposure. Similarly, Birmingham et al [38] 
reported no dermatitis among high school students who attended school 
elsewhere, but younger children attending school in the mining camp did 
have dermatitis. Urinary arsenic levels of the elementary school children
53
were said to "compare favorably" with those reported by Pinto and McGill 
[39] for exposed smelter workers. Thus, dermatitis apparently was seen in 
association with a urinary excretion of 0.8 mg As/liter.
In the study [40] of the English sheep-dip factory, chemical workers 
were shown to have increased cancer mortality while the other 2 occupa­
tional groups did not. The plant was the subject of an environmental- 
clinical survey [41] during which air samples were collected on 5 occasions 
from 4 work areas: in the packing room, drying room, sieving room, and
near the kibbler operator. Additionally, on one occasion 7 samples were 
collected on the mixing platform, by and between the kneading machine, 
while loading and unloading a kiln, and during the blending of ingredients. 
Neither in the epidemiological [40] nor in the environmental [41] portion 
of the study was the "chemical worker" grouping defined or associated with 
particular jobs in the factory. However, based on the job titles included 
in the other 2 groups— packers, engineers (also called maintenance workers 
[41]), builders, printers, watchmen, etc— it appears that those workers in 
the drying room and sieving room, operating the kibbler, kneading, and 
blending machines, and the kilns would be classified as "chemical workers" 
rather than in one of the other occupational groups. Combining all air 
samples from these areas (31 samples) indicates that chemical workers' 
exposure ranged from 0.110 mg As/cu m to 4.038 mg As/cu m with a mean of 
0.562 and a median of 0.379 mg As/cu m. The 4.038 mg As/cu m level was 
almost 4 times the next higher level (1.051 mg As/cu m). Hyperpigmentation 
was observed in 28 of 31 chemical workers examined, and 9 had warts,
54
Chemical workers were excreting 0.23 mg As/liter of urine, and had 108 ppm 
in hair.
Pinto and McGill [39] reported the effects of exposure to arsenic 
trioxide in a copper smelter, but did not report the concentrations to 
which workers were exposed. Effects observed included dermatitis, perfora­
tion of the nasal septum, and conjunctivitis. Urinary arsenic levels were 
reported for "exposed" and "nonexposed” workers. The average excretion 
reported for "nonexposed" workers (0,13 mg As/liter) is the same as that 
reported by Watrous and McCaughey [22] for 13 unexposed job applicants; but 
it is 10 times the level reported (0.014 mg As/liter) by Webster [23] for 
43 persons and is almost twice that reported (0.08 mg As/liter) by Schrenk 
and Schreibeis [4] for 29 persons and by Perry et al [41] for 54 persons 
(0.085 mg As/liter). Additionally, Milham and Strong [47] reported that, 
among people living on a downwind transect from the smelter, urinary 
arsenic levels averaged 0.3 ppm near the smelter but decreased with 
distance from the smelter, falling to 0.02 ppm at a distance of 2.0 - 2.4
miles. The arsenic content of vacuum cleaner dust also declined with 
distance from the smelter. This suggests that there may have been a degree 
of arsenic exposure in the "nonexposed" group since arsenic apparently 
escaped to the community outside the smelter. The "exposed" workers' 
average excretion was 0,82 mg As/liter. Of those found to be excreting 1.0 
to 3.0 mg As/liter, 80% had dermatitis. Everyone excreting over 3.0 mg 
As/liter had dermatitis.
Studying the same plant population, Pinto and Bennett [48] reported 
increased mortality due to respiratory cancer and cardiovascular disease,
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but the increase was not statistically significant. The incidence of 
deaths for these causes was similar among "exposed" and "nonexposed" 
workers, so the authors concluded that the deaths were not related to 
arsenic exposure. As already pointed out, however, the urinary arsenic 
levels reported by Pinto and McGill [39] suggest that there was a degree of 
arsenic exposure in the "nonexposed" group, A 1973 study of this plant 
population by Milham and Strong [47] demonstrated significantly increased 
lung cancer mortality. No environmental data were collected in this study, 
so the incidence of cancer cannot be related to exposure,
A study of a larger smelter population was reported by Lee and 
Fraumeni. [49] In this case, overall mortality was significantly higher 
than expected. Specific causes of death which were significantly higher 
than expected were diseases of the heart, tuberculosis, cirrhosis of the 
liver, and respiratory cancer. Of these, only respiratory cancer was 
significantly higher in all cohorts. Furthermore, respiratory cancer 
mortality was .directly related to length of employment, and to both the 
degree of arsenic exposure and the degree of sulfur dioxide exposure. 
Because there was considerable overlap between these exposure groups, it 
was not possible to separate effects due to each, but it was found that 
workers with heavy arsenic exposure and moderate or heavy sulfur dioxide 
exposure were most likely to die of respiratory cancer.
The data used in part to classify work areas in terms of relative 
arsenic exposures are listed in Table XI-3. These data are highly variable 
and did not form the sole basis for classification, which makes 
interpretation difficult. One area sampled, the arsenic roaster area,
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would be in the heavy exposure classification used by Lee and Fraumeni. 
[49] In this area, samples ranged from 0.10 to 12.66 mg As/cu m with a 
mean of 1,47 and a median of 0.185 mg As/cu m. The reverberatory area and 
the treater building and arsenic loading area, classified as medium arsenic 
exposure areas, ranged from 0,03 to 8.20 mg As/cu m with a mean and median 
of 1.54 and 0.79 mg As/cu m. The remaining 3 areas sampled were areas 
classified as light exposure areas and ranged from 0.001 to 1.20 mg As/cu m 
with a mean and median of 0,206 and 0,010 mg As/cu m, respectively.
Assuming these data to be representative, they indicate that arsenic 
exposures in the "heavy" and "medium" exposure areas were very similar 
overall, although concentrations reached higher levels in the heavy 
exposure area. However, even in the "light" exposure areas, where in these 
samples the average air concentration was 0,206 mg As/cu m, respiratory 
cancer mortality was significantly increased over the expected incidence.
The animal study with the most direct bearing on an occupational 
exposure standard is that by Rozenshtein [57] in which rats were exposed 24 
hours a day to an aerosol of arsenic trioxide at concentrations of 0,06, 
0,0049, and 0,0013 mg As203/cu m (approximately 0,046, 0,004, and 0,001 mg 
As/cu m). One difficulty with this study is that, as grooming animals, the 
rats may have ingested arsenic trioxide from the fur. Another difficulty 
is that occupational standards are based on a 40-hour week, and any 
extrapolation to this from the continuous exposure used by Rozenshtein is 
uncertain. If linearity is assumed, since there is no validated conversion 
formula, the exposure cited would be equivalent to 4,2 times higher levels
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on the 40-hour week basis, or 0.252, 0.021, and 0,005 mg As203/cu m (0.192,
0.016, and 0.004 mg As/cu m).
Rats exposed to the highest concentration of arsenic trioxide 
suffered damage to the central nervous system, a disturbed chronaxial ratio 
of antagonistic muscles, and fatty degeneration of the liver. Similar but 
less severe effects were observed in the intermediate exposure group, but
no ill effects were seen in the lowest. Thus, the threshold apparently was
between the two lower exposure levels which, with the assumptions stated, 
would have been approximately equivalent to 0.004 and 0.016 mg As/cu m on a 
40-hour week basis.
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IV, ENVIRONMENTAL DATA AND BIOLOGIC EVALUATION 
Sampling and Analytical Methods
No direct reading instruments are available for determining arsenic 
in the field. The dusts and fumes of inorganic arsenic compounds can be 
collected by standard filtration including tape sampler, electrostatic 
precipitation, or impingement methods.
Several procedures have been developed for analysis of arsenic in
air. Dubois and Monkman [68] compared three widely used methods on samples
from a variety of sources. The methods tested were Gutzeit, silver
diethyldithiocarbamate, and iodine microtitration. They concluded that the 
silver diethydithiocarbamate method was superior to the others, and 
recommended it because of its sensitivity, accuracy, and suitability over a 
wide range of concentrations. The American Conference of Governmental
Industrial Hygienists evaluated this method [69] by comparing test results 
obtained by eight cooperating laboratories. It was found [69,70] sensitive 
enough to detect, in a 10 cu m air sample, 0.1 yg As/cu m or a maximum of
1.5 yg As/cu m. Thus, sampling times and flow rates must be adjusted to 
collect from 1.0 to 15.0 yg As in the sample. Arsenic is reduced to the 
trivalent state and converted to arsine in a Gutzeit generator. The arsine 
is passed through a scrubber into an absorber containing silver 




Significant exposures are encountered both in the production of 
arsenic compounds and in their use, and good industrial hygiene practices 
must be followed to prevent adverse health effects. Where fumes may be 
present, as in the sintering and roasting of arsenic-bearing ores, complete 
enclosure and exhaust ventilation of the operation is essential. [71] 
Operations that agitate arsenic trioxide dust, eg grinding, screening, 
shoveling, sweeping, and transferring, require control since the dust is 
very fine and disperses easily. [5] When the operation has not been 
sufficiently enclosed and ventilated, supplemental protective clothing and 
respiratory protection may be needed until adequate engineering controls 
are installed.
Arsenic trichloride can cause irritation or ulceration on contact or 
may be absorbed through the skin with fatal results. [20,21] Since its
vapor pressure at 25 C is sufficient to produce an air concentration of
14,000 ppm (104,000 mg/cu m), [71] its handling requires complete
enclosure.
Agricultural uses of arsenic compounds may produce potentially 
hazardous exposures for nearby personnel. Engineering control methods used 
will depend on the equipment and techniques used to apply the chemicals. 




Arsenic absorbed into the human body is excreted in the urine, 
feces, skin, hair, and nails, and possibly a trace from the lungs. 
[3,5,6,26] Even at low doses, a proportion of absorbed arsenic is 
deposited in the skin, hair, and nails where it is firmly bound to keratin. 
[6] Storage in these metabolically "dead” tissues represents a slow route 
of elimination from the body.
Arsenic in hair has been used to monitor workers’ exposure, [22,41] 
but the significance of arsenic in hair is obscured by the difficulty of 
distinguishing externally deposited arsenic from that systemically 
deposited in the hair. Camp and Gant [72] reported that "there is no way 
to differentiate 'interior' and ’exterior’ arsenic." Similarly, Watrous 
and McCaughey [22] reported that once arsenic was deposited on the hair, it 
resisted washing with ether and water, and they considered determinations 
of arsenic in hair to be completely unreliable. The level of arsenic in 
fingernail and toenail parings reflects past absorption and is therefore 
useful forensically, but is less useful if the goal is to monitor current 
absorption.
Most authors agree that the urine is a major route of arsenic 
excretion. [3,6,24] Arsenic can be detected in the urine of people with'no 
known exposure to arsenic, apparently derived from dietary and general 
environmental sources. [2,4] However, the urine of workers occupationally 
exposed to arsenic may show much higher levels than that of the unexposed, 
even in the absence of signs of systemic arsenic poisoning. [4,39,22]
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Webster [23] collected urine samples from 26 adults and 17 children 
and reported that the average arsenic content was 0.014 mg As/liter with an 
average specific gravity of 1.017, Corrected to a specific gravity of
1.024, Webster's average was 0,02 rag As/liter.
Schrenk and Schreibeis [4] collected 756 urine specimens from 29 
persons with no known industrial exposure to or abnormal dietary uptake of 
arsenic. The overall average urinary excretion was 0.08 mg As/liter, and 
79% of the samples were less than 0.1 mg As/liter. After the authors found 
that seafood could affect urinary arsenic levels, they excluded values when 
it was known that the subject had eaten seafood. However, some values, 
which apparently had been influenced by seafood, were included beifore sea­
food was recognized as a factor. Since no record of diet had been kept, 
these unusually high values could not be excluded (the three highest 
samples were 2.0, 1.1, and 0.42 mg As/liter).
Seafood was considered [4] to be the main source of dietary arsenic. 
Shellfish in particular elevated the arsenic of test subjects. In one 
test, three subjects with pretest levels of 0,01, 0.03, and 0,05 mg
As/liter were given lobster tail for lunch. Four hours after eating, 
urinary levels were 1.68, 0.78, and 1.40 mg As/liter, respectively, Ten 
hours after eating, levels were 1.02, 1.32, and 1.19 mg As/liter. After 24 
hours values were 0.39, 0.39, and 0.44 mg As/liter, and at 48 hours, values 
were approaching the pretest levels.
Rapid initial excretion of inhaled arsenic was reported by Holland 
et al, [24] with 28% of the absorbed As-74 being excreted in the urine 
within the first day after it was inhaled, and 45% within 10 days. An
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additional 2.5% had been excreted in the feces after 10 days} but the
remaining 52,5% was not accounted for.
Pinto and McGill analyzed [39] the urine of 348 men (845 spot 
samples) occupationally exposed to arsenic trioxide and reported a mean 
level of 0.82 mg As/liter. The median value was 0.58 rag As/liter, and 
27.3% of the samples exceeded 1.0 mg As/liter. One hundred forty-seven 
urine samples from 124 active smelter employees considered to have no 
arsenic exposure averaged 0.13 rag As/liter. The three highest values were 
0.53, 0.70, and 2.06 mg As/liter, but 88% of the samples were below 0.2 mg
As/liter. Although it was stated that among the exposed workers there was 
only one dubious case of mild systemic arsenic poisoning, there were 
several cases (at least 17) of acute arsenical dermatitis. Over a 6-day
period, sixteen of these had average urine arsenic levels, during or 
following British Anti-Lewisite (BAL) therapy, ranging from 0.30 to 0.93 mg 
As/liter. One individual with severe facial dermatitis of rapid onset 
received BAL every six hours for four days, but excreted an average of only 
0.2 mg As/liter. It was surmised that this man was hypersensitive or 
allergic to arsenic. One individual who declined BAL therapy had urinary 
arsenic levels ranging from 3.15 to 5.76 mg As/liter over a two-day period. 
According to these authors, [39] individuals may show urinary arsenic 
levels in spot samples as high as 4 or 5 mg As/liter, without any evidence 
of systemic arsenic poisoning.
In the English sheep-dip factory, [41] urinary arsenic levels were
determined for workers exposed to mixed arsenic trioxide and sodium
arsenite dusts, and for unexposed controls. The urinalyses of exposed
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personnel were repeated after an interval of six months. The mean urinary 
arsenic level for 54 controls was 0.085 mg As/liter, and in 58 
determinations made on chemical workers (the most heavily exposed group), 
the mean was 0.231 mg As/liter (computed from the data given in Tables 6 
and 7 by Perry et al [41]). The 3 highest levels recorded in the exposed 
group were equivalent to 0.73, 1.01, and 1.91 mg As/liter. Most of the 
chemical workers (28 of 31) had evidence, in the form of pigmentation and 
warts, of past systemic arsenicalism. Air samples were collected at a 
number of locations where chemical workers apparently were employed, and 
the mean arsenic concentration in these areas can be computed from data in 
Table 3 [41] as 0.562 mg As/cu m.
Thus, urinary arsenic levels of people with no known arsenic 
exposure have been reported as 0.014 (0,020 corrected to a specific gravity 
of 1.024), [23] 0.08, [4] 0.085, [41] 0.129, [22] and 0.13 mg As/liter.
[39] Some of the unexposed individuals tested had urinary levels as high 
as 2.0 mg As/liter, [4,39] but these high levels may have been due to 
unusual dietary intake [4] or to unrecognized arsenic exposure. [39]
The urinary arsenic levels of exposed workers vary widely and levels 
above 4.0 mg As/liter have been reported [39] without apparent adverse 
effects. On the other hand, signs of mild systemic poisoning have been 
reported [22] in a worker excreting only 0.76 mg As/liter. This wide 
variability in urinary arsenic levels, even in an apparently unexposed 
population, combined with inability to demonstrate a definite association 
between urinary levels and either observed effects or atmospheric 
concentrations makes interpretation of urinary data difficult.
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Nevertheless, a biological threshold limit value of 1.0 mg As/liter of 
urine was proposed by Elkins. [73] This was considered to be roughly 
consistent with a time-weighted average air level of 0.5 mg As/cu m. [74]
Of all the papers discussed in this document, only Webster [23] 
reported the specific gravity of the sample tested, Elkins, [73,74] Elkins 
and Pagnotto, [75] Buchwald, [76] and Levine and Fahy [77] all point out 
the importance of correcting to a mean specific gravity in order to obtain 
meaningful and consistent results. Testing persons in the United Kingdom, 
Buchwald [76] reported the mean specific gravity was 1.016. However, in 
the United States, Elkins, [73,74] and Elkins and Pagnotto [75] recommend
1.024, This was based on the findings of Levine and Fahy, [77] who in 1945 
reported 1.024 as the mean specific gravity of nearly 1,200 urine samples. 
According to Elkins and Pagnotto, [75] their laboratory has analyzed 1,000 
to 2,000 urine samples annually since the Levine and Fahy report, and 1.024 
is still the mean specific gravity used. However, care must be exercised 
when making specific gravity corrections to express the specific gravity of 
the urine in relation to that of water at the same temperature. If a 
urinometer calibrated against water at 4 C is used, then a correction for 
temperature should also be employed. [75,77]
Citing urinary levels reported by Pinto and McGill [39] for exposed 
workers with no signs of poisoning, Schrenk and Schreibeis [4] concluded 
that, while no relationship could be shown between urinary arsenic levels 
and evidence of poisoning, "urinary arsenic levels in a group of exposed 
persons may serve to check the efficacy of control measures and indicate if 
excessive absorption of arsenic occurs." Referring to the inconsistency
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with which the workers wore their respirators, Pinto and Bennett [48] 
wrote: "It is for this reason we depend on the urinary arsenic level as
showing the men are exposed to arsenic-containing dusts. The simple 
measurement of arsenic dust in the air is not a good measure of how much 
arsenic has been absorbed by an individual."
Monitoring urinary arsenic cannot replace monitoring atmospheric 
concentrations as the primary method of characterizing the workers' 
exposure, It seems reasonable that group averages may be useful as a check 
on the adequacy of the overall program of engineering controls and work 
practices designed to protect the workers' health.
V. DEVELOPMENT OF THE STANDARD 
Basis for Previous Standards
The American Standards Association (now the American National 
Standards Institute) in 1943 proposed 0.015 mg As/cu m as an American War 
Standard for inorganic arsenic. [78] However, the summary of standards 
compiled by Cook [79] shows that by 1945 the War Standard had been 
increased by a factor of 10 to 0.15 mg As/cu m, set on the basis of analogy 
with other metals such as cadmium and lead. The 0.15 mg As/cu m standard 
was also adopted by Connecticut, Massachusetts, New York, and Oregon, but 
Utah endorsed a Maximum Acceptable Concentration (MAC) of 0.5 mg/cu m. [79] 
In his discussion of the 0.15 mg As/cu m standard, Cook stated that "On the 
basis of long experience [undescribed] involving many occupational 
exposures, at least one large concern considers it permissible to increase 
the limit to 5, mg, per cubic meter."
In 1947 the American Conference of Governmental Industrial 
Hygienists (ACGIH) adopted an MAC for arsenic of 0,1 mg/cu m, [80] but the 
following year this was raised to a Threshold Limit Value (TLV) of 0.5 mg 
As/cu m. [81] The ACGIH gave no explanation for the change, but Pinto, 
commenting in a July 1972 written communication to ANSI on the 0.5 mg As/cu 
m standard, stated that arsenic trioxide was considered to be the primary 
arsenic compound to which there was industrial exposure, and the 0.5 mg 
As/cu m level was suggested as a safe concentration of arsenic trioxide, 
with "safe concentration" meaning that "it would not cause incapacitating 
dermatitis in a few hours." Whether the change from an MAC to a TLV 
constituted a change from a ceiling of 0.1 mg/cu m to a time-weighted
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average of 0.5 mg/cu m is not clear. If that was the case and one applies 
the excursion factor of 3 presently recommended by the ÁCGIH [82] for TLVs 
in the 0.0 to 1,0 mg/cu m range, this change constituted a 15-fold 
increase, The present TLV recommended by the ACGIH is 0.5 mg As/cu m for 
"arsenic and compounds." [82]
In his 1959 textbook, Elkins [73] recommended a maximum allowable 
concentration of 0.25 mg/cu m for arsenic trioxide, equivalent to 0.19 mg 
As/cu m. There was little discussion given of safe exposure levels, but 
the Watrous and McCaughey [22] report of concentrations averaging almost
0.2 mg As203/cu m in the manufacturing department of a pharmaceutical plant 
apparently was a major consideration.
Separate TLVs for lead arsenate and calcium arsenate have been 
recommended by the ACGIH for a number of years, A limit of 0,15 mg/cu m 
for lead arsenate (equivalent to 0,026 mg As/cu m) was adopted tentatively 
in 1956, [83] confirmed in 1957, [84] and has remained unchanged since. 
[82] According to the ACGIH Documentation, [85] this compound was 
considered to present the double hazard of both lead and arsenic 
intoxication. The chronic toxicity was attributed to the lead content and 
the acute toxicity to the arsenic, although it was considered less acutely 
toxic than calcium arsenate. [85]
A limit of 0.1 mg/cu m (equivalent to 0.038 mg As/cu m) for calcium 
arsenate was originally recommended by the ACGIH in 1956, [83] and was
adopted in 1957. [84] In his review of standards, Smyth [86] attributed
the toxicity of calcium arsenate to the arsenic content, Considering it to 
be 20% arsenic, he recommended a standard of 2.5 mg/cu m to be consistent
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with the ACGIH recommended standard of 0.5 mg As/cu m for ’’arsenic and 
compounds/1 The ACGIH documentation [85] cited Smyth [86] as attributing 
the toxicity to the arsenic content, but the TLV recommended for calcium 
arsenate was 1.0 mg/cu m (equivalent to 0.38 mg As/cu m). This discrepancy 
was not explained.
The Czechoslovak MAC Committee suggested a “mean MAC" of 0.3 and a 
"peak MAC" of 0.5 mg As/cu m, [87] The documentation did not give reasons 
for the levels chosen, but did state the following MACs for other
countries: Great Britain, the United States, West Germany, and Yugoslavia,
0,5 mg As/cu m; East Germany, Hungary, and the USSR, 0.3 mg As/cu m; and 
Poland, 0.15 mg. As/cu m. It was not stated whether these MACs were
ceilings or time-weighted averages.
The present Federal standard for "arsenic and compounds" is 0.5 mg 
As/cu m as a time-weighted average. There are separate standards, both
determined as a time-weighted average, for calcium arsenate (1.0 mg
Ca3(As04)2/cu m) and for lead arsenate (0.15 mg Pb3(As04)2/cu m). [29 CFR
1910.93, published in the Federal Register, vol 37, dated October 18, 1972] 
These standards were based on the ACGIH recommendations.
Basis for Recommended Environmental Standard
A number of signs and symptoms are associated with arsenic 
poisoning. When ingested, arsenic compounds can cause nausea, vomiting, 
and diarrhea within a few hours, [25,27] although in at least one animal 
study [50] with arsenic trioxide, much of the gastrointestinal irritation 
was attributed to impurities. Dermatitis may be observed [25] after
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chronic ingestion, but the typical signs of chronic arsenicalism are
hyperpigmentation and hyperkeratosis, especially on the palmar and plantar 
surfaces, [25,27,33] and peripheral neuropathy [25,27] in a glove and 
stocking distribution with prickly sensations [25,29] and loss of distal 
proprioception and deep tendon reflexes. [25] Changes in the ECG have been 
reported after both acute [31,32] and chronic [29,32] intoxication, 
although in at least one report [25] of severe chronic arsenicalism, the 
patient's ECG was normal, ECG changes that were observed [29,31,32]
regressed after arsenic exposure ceased. Anemia and leucopenia were
reported [27] in cases of chronic intoxication, but these changes also 
regressed after arsenic ingestion ended. Effects on the liver include 
cirrhosis after prolonged use of Fowler's solution, [33] and, in animal 
studies, marked enlargement of the bile duct [55] and fatty degeneration of 
the liver. [57] Skin cancer has long been considered [10] a consequence of 
arsenic exposure, but multiple cancers of the viscera have also been
reported. [36] However, the association too often was made because a 
cancer patient exhibited hyperpigmentation and hyperkeratoses. On this 
basis, cases were included both in Neubauer's review [10] in which 147 
cases were collected and in the cases reported by Sommers and McManus [36] 
despite the fact that in some cases there was no known arsenic exposure.
No reports were found of occupational exposure to arsenic compounds 
resulting in nausea, vomiting, diarrhea, or peripheral neuropathy. Occu­
pational exposures have been reported to cause hyperpigmentation, [28,41] 
palmar and plantar hyperkeratoses, [28] warts, [28] contact dermatitis and 
sensitization, [37-39] ulceration and perforation of the nasal septum,
70
[38,39] and conjunctivitis, [39] Reversible ECG changes [30] and severely 
reduced peripheral circulation resulting in gangrene of the fingers and 
toes [28] have been reported. Cirrhosis of the liver has been observed, 
[28,46] and one epidemiological study [49] reported significantly increased 
mortality due both to cirrhosis of the liver and to cardiovascular disease. 
Two studies reported that cancer [42,48] and cardiovascular [48] mortality 
were not significantly increased in workers exposed to arsenic, but the 
mortality experience of workers in the same plant studied by one of these 
[48] was examined again [47] in 1973 and significantly increased lung
cancer mortality was reported, Other studies have reported cancer of the 
skin, [40,46] lung, [40,46,49] and other organs. [46] In general, attempts 
to produce cancer experimentally in animals have failed, [55,56,65,66] but 
leukemia reportedly [67] has been induced experimentally and teratogenic 
effects have been observed in animals. [60-62]
Atmospheric data were not included in the studies reporting
dermatitis, [37-39] ulceration and perforation of the nasal septum, [38,39] 
conjunctivitis, [39] ECG changes, [30] disturbed peripheral circulation, 
[28] or cirrhosis of the liver, [28,46] The question of air levels was 
approached only by Pinto and McGill, [39] who considered dust-in-air 
measurements to be of limited value for predicting skin reactions.
ECG changes reported after nonoccupational [29,31,32] and occupa­
tional [30] exposure to arsenic have apparently been reversible. One epi­
demiological study [48] of a copper smelter reported that observed deaths 
due to cardiovascular disease exceeded the expected, but the difference was 
not statistically significant. Another study [49] of a smelter population
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found that, compared to statistics for the state in which the smelter was 
located, mortality due to heart disease was significantly increased. In 
terms of length of employment, cardiovascular mortality was significantly 
increased in 4 of 5 cohorts, and the excess mortality was approximately the 
same in each of these 4 cohorts. In both smelter studies, [48,49] 
exposures were to many compounds other than arsenic. However, the fact 
remains that arsenic apparently caused at least temporary ECG changes [29- 
32] and may have caused increased cardiovascular mortality, [48,49]
Cirrhosis of the liver has been reported as a result of prolonged 
use of Fowler's solution [33] and among German vineyard workers. [28,46] 
In the latter studies, ethyl alcohol may have been at least a contributor, 
since in one report [28] many of the vineyard workers were said to drink 2 
liters or more of wine daily. A recent epidemiological study [49] of an 
American smelter population found increased mortality due to cirrhosis of 
the liver, but the increase apparently was not related to length of 
exposure. Animal studies have reported liver damage after ingestion of 
either sodium arsenite or arsenate [55] and after inhalation of arsenic 
trioxide. [57] Thus the potential for liver damage seems real, but it is 
not clear whether occupational exposures have actually resulted in damage, 
and if so, at what concentration.
Two mortality studies [42,48] of smelter populations have reported 
that observed cancer mortality exceeded the expected mortality but not 
significantly. These authors concluded that workers exposed to arsenic did 
not experience increased cancer mortality, but that conclusion is open to 
question. In the Snegireff and Lombard study, [42] the authors examined
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and discussed only overall cancer mortality. However, according to a 
comparison made by NIOSH, respiratory cancer mortality as a proportion of 
total cancer deaths was 5.7 times expected in the plant at which arsenic 
trioxide was handled and 6.5 times expected in the comparison plant at 
which arsenic was not handled. Thus, both plants apparently had increased 
respiratory cancer mortality, although overall cancer mortality was not 
significantly increased,
The Pinto and Bennett study [48] was followed in 1973 by the Milhan 
and Strong report [47] of mortality among workers at the same plant. These 
authors [47] found that lung cancer mortality was significantly higher than 
expected. As reported by Hill and Faning, [40] the cancer mortality of 
chemical workers in the English sheep-dip factory was significantly 
increased. The small numbers involved made firm conclusions difficult, but 
the authors suggested that the excess could be attributed to increased lung 
and skin cancer mortality. Lee and Fraumeni [49] reported not only that 
respiratory cancer mortality was significantly increased, but also that the 
incidence of respiratory cancer increased with length of employment as well 
as with the degree of arsenic exposure.
These studies [40,47,49] strongly implicate arsenic as an 
occupational carcinogen. However, the relationship is obscured because, in 
the smelting industry, the workers were exposed to a variety of substances 
other than arsenic, one of which was sulfur dioxide. In the Lee and 
Fraumeni report, [49] lung cancer mortality increased with increasing 
arsenic exposure; but generally the sulfur dioxide levels increased with 
the arsenic levels. It was not possible to examine the mortality of a
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subgroup exposed only to arsenic or only to sulfur dioxide, so a role by 
sulfur dioxide or some other substance cannot be ruled out in the smelting 
industry. However, the involvement of arsenic can hardly be denied. There 
was no suggestion of sulfur dioxide exposure in the sheep-dip factory, 
[40,41] but cancer mortality was still significantly increased. [40]
Environmental data with which to establish a safe exposure level are 
scant. In the English sheep-dip factory study, [40,41] increased cancer 
mortality was observed among chemical workers. [40] The average exposure 
of chemical workers can be computed as 0.562 mg As/cu m from the air 
concentrations reported by Perry et al [41] by assuming that all samples 
reported, with the exception of 6 samples from the packing room where 
workers apparently would be classified as packers, were collected in areas 
in which chemical workers were employed. Increased lung cancer mortality 
was reported by Lee and Fraumeni [49] in all cohorts, including the group 
with only 1 to 4 years of employment, and in all exposure groups, including 
those with light arsenic exposure. The sparse data (12 samples from three 
'’light” exposure areas) with which to characterize these work areas range 
from 0.001 to 1.20 mg As/cu m with a mean and median of 0.206 and 0.01 mg 
As/cu m, respectively (Table XI-3). With the exception of the pharma­
ceutical plant study, [22] no environmental data were published in any of 
the other reports examined.
Even if contact dermatitis and systemic toxicity were the only bases 
for establishing a standard, it is evident that the existing Federal 
standard of 0.5 mg As/cu m is too high because, according to Pinto in a 
July 1972 written communication to ANSI, it was originally established to
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prevent "incapacitating dermatitis in a few hours," clearly an inadequate 
basis from present-day considerations. However, more recent reports 
[40,47,49] associate inorganic arsenic with occupational cancer. The Lee 
and Fraumeni report [49] strongly suggests that exposure at or around 0.2 
mg As/cu m [Table XI-3] can result in an increased incidence of cancer. 
Because of the seriousness of the disease, prudence dictates that the 
standard should be set at least as low as 0,05 mg As/cu m. It is believed 
that exposure at this level should, at the minimum, significantly reduce 
the incidence of arsenic-induced cancer.
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VII. APPENDIX I 
AIR SAMPLING PRACTICES FOR ARSENIC
General Requirements
Air concentrations shall be determined within the worker’s breathing 
zone and shall meet the following criteria in order to evaluate conformance 
with the standard:
(a) Samples collected shall be representative of the individual
worker’s exposure.
(b) Sampling data sheets shall include:
(1) The date and time of sample collection
(2) Sampling duration
(3) Volumetric flowrate of sampling
(4) A description of the sampling location
(5) Other pertinent information 
Breathing Zone Sampling
(a) Breathing zone samples shall be collected as near as
practicable to the worker's face without interfering with his freedom of 
movement and shall characterize the exposure from each job or specific 
operation in each production area.
(b) A portable battery-operated personal sampling pump plus an
unweighed 0.8 \i cellulose membrane filter (Type AA) mounted in either a 2- 
or 3-piece cassette shall be used to collect the sample.
(c) The sampler shall be operated at a flowrate of two liters per 
minute and samples taken for at least 15 minutes. A sampling time of 30 to 
60 minutes is recommended.
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(d) A minimum of three samples shall be taken for each operation 
(more samples if the concentrations are close to the standard) and averaged 
on a time-weighted basis.
(e) A minimum of three blank filters carried in closed cassettes 
to the sampling site shall be provided to the analytical laboratory to 
determine the background correction which must be applied to the analytical 
results,
Calibration of Sampling Trains
Since the accuracy of an analysis can be no greater than the accuracy 
of the volume of air which is measured, the accurate calibration of a 
sampling pump is essential to the correct interpretation of the volume 
indicated. The frequency of calibration is dependent on the use, care, and 
handling to which the pump is subjected. In addition, pumps should be 
recalibrated if they have been subjected to misuse or if they have just 
been repaired or received from a manufacturer. If the pump receives hard 
usage, more frequent calibration may be necessary.
Ordinarily, pumps should be calibrated in the laboratory both before 
they are used in the field and after they have been used to collect a large 
number of field samples. The accuracy of calibration is dependent on the 
type of instrument used as a reference. The choice of calibration 
instrument will depend largely upon where the calibration is to be 
performed. For laboratory testing, a 1-liter burette or wet-test meter is 
recommended, although other standard calibrating instruments such as 
spirometer, Marriott*s bottle, or dry-gas meter can be used. The actual 
set-up will be the same for these instruments.
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Instructions for calibration with the wet-test meter follow. If 
another calibration device is used, equivalent procedures should be 
followed,
(a) The calibration device used shall be in good working condition 
and shall have been calibrated against a soapbubble meter, spirometer, or 
other primary standard upon procurement, after each repair, and at least 
annually.
(b) Calibration curves shall be established for each sampling pump 
and shall be used in adjusting the pumps prior to field use.
(c) The volumetric flowrate through the sampling system shall be 
spot checked and the proper adjustments made before and during each study 
to assure obtaining accurate airflow data.
(d) Flowmeter Calibration Test Method (see Figure XI-1)
(1) Apparatus
(A) Wet test meter
(B) Quick connector or by-pass valve




(F) Pump with rotameter








(A) Level wet test meter. Check the water level
which should just touch the calibration point at the left side of the
meter. If water level is low, add water 1 to 2 F warmer than room temper­
ature to fill point. Run the meter for 30 minutes before calibration.
(B) Check the voltage of the pump battery with a
voltmeter. This test is most indicative of battery conditions when
performed under full load, ie with the pump motor operating.
(C) Mount the filter to be calibrated in the in-line
filter holder.
(D) Assemble the calibration train as shown in 
Figure XI-1. Leave the quick connector disconnected.
(E) Turn the pump on, adjusting the rotameter with a 
screwdriver to a reading of 10 (read middle of the float).
(F) Connect the wet test meter to the train. The 
pointer on the meter should run clockwise and a pressure drop of not more 
than 1.0 inch of water indicated. If the pressure drop is greater than 1.0 
disconnect and check the system.
(G) Operate the system ten minutes before starting
the calibration.
(H) Record the following on calibration data sheets:
(i) Viet test meter reading, start and finish
(ii) Elapsed time, start and finish
85
(iii) Pressure drop at manometer
(iv) Air temperature
(v) Barometric pressure
(vi) Serial number of pump and rotameter
(I) Adjust the rotameter reading to 9.0, 8.0, and
7.0, respectively, and repeat step (H) at each reading. For each point, 
the system should run for 10 minutes or sample at least 0.5 cubic foot of 
air.
(J) Record the name of the person performing the
calibration, the date, serial number of the wet test meter, and the numbers 
of the pump and flowmeter system being calibrated.
(K) Corrections to the flow rate may be necessary if
the pressure or temperature when samples are collected differs 
significantly from that when calibration was performed. Flow rates may be 
calculated using the following formula:
q(actual) = q(indicated) * \lf (cill^krated) t T(calibrated),
P(actual) T(actual)
where q = volumetric flowrate
P = pressure
T = temperature (in degrees Kelvin or Rankine)
(L) Use graph paper to record the actual airflow as 
the ordinate and the rotameter readings as the abscissa.
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VIII. APPENDIX II 
ANALYTICAL METHOD FOR 
ARSENIC IN AIR [69,70]
Treatment of Sample: The filter or precipitator sample is rinsed
into a beaker with a stream of 1% sodium hydroxide solution, followed by a 
distilled water rinse. The volumes of both rinse liquids are kept at a 
minimum. The alkali is neutralized by dropwise addition of concentrated 
hydrochloric acid using phenolphthalein indicator. The cooled solution is 
transferred and made up to 50 ml in a volumetric flask. Impinger samples 
are made up to a 50 or 100 ml final volume as convenient. If water was 
used in the impinger no neutralization is required.
Analysis: Known microgram amounts of arsenic (1-15 yg) in the form
of standard arsenic solution, are pipetted into 125 ml Erlenmeyer flasks. 
Distilled water is added to make the total volume 35 ml. To the flasks are 
added 5 ml hydrochloric acid, 2 ml 15% potassium iodide solution, and 8 
drops of stannous chloride solution. The flasks are swirled, and allowed 
to stand for 15 minutes to ensure reduction of all arsenic to the trivalent 
form.
Three milliliters of the pyridine solution of silver diethyl- 
dithiocarbamate are placed in the absorbing tube, which is attached to the 
scrubber containing glass wool impregnated with lead acetate.
The ground joints are lubricated with stopcock grease, 3 g of 
granulated zinc are added to the solution in the flask, and the receiving 
tube is inserted immediately. Arsine evolution is completed in about 30 
minutes,
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At the end of this time the absorbing solution is transferred to a 
square 1 cm cell and the absorbance measured at 560 nanometers in a 
spectrophotometer. Plotting measured absorbances against micrograms of 
arsenic taken produces the standard curve. Care should be taken when 
preparing standard curves, since some arsenic can leach from new glassware 
and could influence a standard curve.
Air samples, after the previously described preparation treatment, 
are treated in the same manner as the standards. Depending upon the 
operator’s knowledge of the sampling conditions, a sample or aliquot of a 
sample representing from 1.0 to 15,0 yg of arsenic should be taken for 
analysis. From previous experience with known amounts of arsenic the 
operator can decide from the color of the absorbing solution whether the 
sample aliquot taken will be within the range of the calibration curve. If 
necessary, the prepared sample may be diluted, or the volume of the 
absorbing solution may be varied to adjust the color intensity to the scale 
of the standard curve.
Chemical Reaction: Arsenic, in the form of arsine, displaces an
equivalent amount of silver from silver diethyldithiocarbamate in pyridine
solution.
Calculations: If a 25 ml aliquot of a 50 ml prepared sample is taken
for analysis, and 3 ml of absorbing solution are used, the arsenic
concentration in milligrams per cubic meter is:
2 X micrograms arsenic from curve 
1000 X volume of air sampled in cubic meters
Range and Sensitivity: If suitable samples (10 cu m of air) are
available, concentrations as low as 0.1 yg As/cu m can be measured. The 
maximum measureable concentration with a comparable sample is 1.5 yg As/cu 
m. Higher concentrations can be measured if smaller samples are used.
Precision and Accuracy: Samples containing 0.1, 1,0, 5.0, and 10.0
yg As were analyzed [70] with an accuracy of ±0.04 yg based on 7 replicate 
determinations at each concentration. Four samples containing arsenic were 
analyzed [70] by eight laboratories and the percent average deviation from 


















^Contained 0.5 yg Sb/ml
Interferences: The only substances likely to interfere with the test
are hydrogen sulfide, which is normally removed by the lead acetate glass
wool plug, and stibine. Sample 3 above [70] contained 0.5 yg Sb/ml in 
addition to the arsenic present. The results indicate that stibine, due to 
antimony present in the sample, does not interfere in the amount present.
Special Equipment: The equipment illustrated in Figure XI-2 has been
found convenient, easy to construct and clean, and suitable for mass
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production of results. It is available commercially or may be built. 
Other arrangements of glassware have been used with success, such as a 
standard borosilicate glass Gutzeit generator connected to a glass delivery 
tip extending into absorbing solution contained in a Kahn tube. A
spectrophotometer, with or without photomultiplier, or any good colorimeter 
may also be used.
Reagents: Silver diethyldithiocarbamate [AgSCSN(C2H5)2] reagent:
Dissolve 4.0 g of silver diethyldithiocarbamate in 800 ml of pyridine. The 
useful life of this reagent can be extended to at least two months by
storing in a dark brown bottle or in the dark.
Stannous chloride reagent: Dissolve 10.0 g of fresh supply of
stannous chloride dihydrate in 25 ml of 12N (specific gravity 1.19) 
hydrochloric acid. Place in a separatory funnel with a layer of pure
mineral oil 5 mm thick on top to minimize oxidation. Drain a small
quantity of the solution out of the stopcock before use. This solution is 
stable for 2 weeks.
Lead acetate solution: Dissolve 10 g of Pb(C2H302)2 3H20 crystals in
100 ml of water. The solution will be slightly turbid as a small amount of 
the basic salt is formed, but this will not affect its usefulness. The 
glass wool in the scrubber may be soaked in this solution, drained, and
dried, or a few drops may be placed on the glass wool before the evolution
of arsine.
Potassium iodide solution: Dissolve 15 g of KI in 100 ml of water.
The solution should be stored in a brown glass bottle.
Zinc: Reagent grade, granular 20 mesh.
Arsenic standard stock solution: 1.320 g arsenic trioxide is
dissolved in 10 ml of 40% sodium hydroxide and diluted to 1 liter with 
distilled water. Various strengths of standard solutions are prepared by 
further diluting this stock solution with suitable volumes of water.
The water used to make up the reagents, and throughout the analysis, 
is triple distilled in borosilicate glass. Naturally, all reagents used 
should be checked to ensure a low individual and a low total reagent blank.
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IX. APPENDIX III 
ANALYTICAL METHOD FOR 
ARSENIC IN URINE [68-70]
At least 100 ml of urine should be collected. Determine the specific 
gravity of the sample before further treatment.
Oxidation: Place 100 ml of urine in a 300 ml Kjeldahl flask, add 5
ml concentrated H2S04 and 25 ml concentrated HN03. Boil over a full flame 
under the hood. The addition of acid may cause the sample to darken, but 
the heating will lighten the color. Continue the heating to concentrate 
the sample. No trouble should be experienced with bumping. As the sample 
becomes quite concentrated, it will foam considerably. At this point it 
should be watched carefully for signs of darkening. If there is darkening, 
add a few drops of concentrated HN03 from a pipette dipped into a tube of 
the acid. Only sufficient acid should be added to overcome the darkening. 
Finally, the liquid should be water-white and fumes of sulfuric acid will 
be evolved. Further bleaching of the solution may be obtained by 
cautiously adding 2 ml of a 1:1 mixture of nitric and perchloric acids, and 
reheating to produce white fumes. Cool slightly and add 5 ml of saturated 
ammonium oxalate. Heat again until white fumes appear. This oxidation may 
be completed in less than two hours.
Analysis: Transfer the oxidized sample with the aid of 25 ml of
water to a 100 ml conical flask. Cool to room temperature. Add 5 ml of 
10% potassium iodide and 4 drops of stannous chloride. Let stand 15 
minutes. Add 3.0 g of zinc and, using the same equipment as in determining
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arsenic in air (see Figure XI-2), follow the same procedures as for air 
samples.
Calculations: Determine absorbance produced by 10 or 20 y g As at 560
nm, For example, if the increase in absorbance produced by 10 \ig As is
found to be 0.440, then:
( A-B ) - yg -¿n aliquot
0.044
where A = absorbance in sample, and B = absorbance of blank run on
reagents. Calculate as mg As/liter of urine. Adjust to mean specific
gravity of 1,024,
Reagents: Prepare as in analysis for determination of arsenic in
air,
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X, APPENDIX IV 
MATERIAL SAFETY DATA SHEET
The following items of information which are applicable to a specific 
product or material containing arsenic or arsenic compounds shall be 
provided in the appropriate section of the Material Safety Data Sheet or 
other approved form, If a specific item of information is inapplicable 
(eg, flash point), the initials "n.a." (not applicable) should be inserted.
(a) The product designation in the upper left hand corner of both 
front and back to facilitate filing and retrieval. Print in upper case 
letters as large as possible.
(b) Section I, Name and Source.
(1) The name, address, and telephone number of the
manufacturer or supplier of the product,
(2) The trade name and synonyms for a mixture of chemicals,
a basic structural material, or for a process material; and the trade name 
and synonyms, chemical name and synonyms, chemical family, and formula for 
a single chemical,
(c) Section II. Hazardous Ingredients.
(1) Chemical or widely recognized common name of all
hazardous ingredients.
(2) The approximate percentage by weight or volume
(indicate basis) which each hazardous ingredient of the mixture bears to 
the whole mixture. This may be indicated as a range or maximum amount, eg, 
10-20% V; 10% max. W.
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(3) Basis for toxicity for each hazardous material such as 
established OSHA standard (TLV), in appropriate units and/or LD50, showing 
amount and mode of exposure and species or LC50 showing concentration and 
species,
(d) Section III, Physical Data,
Physical properties of the total product including boiling 
point and melting point in degrees Fahrenheit; vapor pressure, in milli­
meters of mercury, vapor density of gas or vapor (air « 1), solubility in 
water in parts per hundred parts of water by weight; specific gravity 
(water = 1); percent volatile, indicate if by weight or volume, at 70
Fahrenheit; evaporation rate for liquids (indicate whether butyl acetate or 
ether = 1); and appearance and odor,
(e) Section IV. Fire and Explosion Hazard Data.
Fire and explosion hazard data about a single chemical or a 
mixture of chemicals, including flash point, in degrees Fahrenheit; 
flammable limits, in percent by volume in air; suitable extinguishing media 
or agents; special fire fighting procedures; and unusual fire and explosion 
hazard information.
(f) Section V, Health Hazard Data.
Toxic level for total compound or mixture, relevant symptoms 
of exposure, skin and eye irritation properties, principal routes of ab­
sorption, effects of chronic (long-term) exposure and emergency and first 
aid procedures.
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(g) Section VI. Reactivity Data.
Chemical stability, incompatibility, hazardous decomposition 
products, and hazardous polymerization.
(h) Section VII. Spill or Leak Procedures.
Detailed procedures to be followed with emphasis on pre­
cautions to be taken in cleaning up and safe disposal of materials leaked 
or spilled. This includes proper labeling and disposal of containers 
containing residues, contaminated absorbants, etc.
(i) Section VIII. Special Protection Information.
Requirements for personal protective equipment, such as
respirators, eye protection and protective clothing, and ventilation such 
as local exhaust (at site of product use or application), general, or other 
special types.
(j) Section IX. Special Precautions.
Any other general precautionary information such as personal 
protective equipment for exposure to the thermal decomposition products 
listed in Section VI, and to particulates formed by abrading a dry coating, 
such as by a power sanding disc.
(k) The signature of the responsible person filling out the data 
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PHYSICAL AND CHEMICAL PROPERTIES OF 
IMPORTANT INORGANIC ARSENICALS
Arsenic., As
Physical state: gray metal, hexagonal-rhombic crystals
also yellow cubic crystals (As4)
Atomic weight: 74.9216
Specific gravity: 5,727
Melting point: sublimes at 613 C
Solubility: insoluble in water
Arsenic Trichloride, AsCl3
Physical state: oily liquid or needle shaped crystals
Formula weight: 181.28
Specific gravity: 2,163 (20 C)
Melting point: -8.5 C
Boiling point: 130,2 C
Vapor density: 6,25 (air - 1)
Vapor pressure: 10 mm Hg (23.5 C)
Solubility: decomposes in water
Percent arsenic: 41
Arsenic Trioxide, As203 (White Arsenic, Arsenous Oxide)
Physical state: transparent crystals or amorphous white powder
Formula weight: 197.84
Specific gravity: 3,738
Melting point: 315 C
Solubility, in g/lOOcc water: 3.7 at 20 C, 10.14 at 100 C
Percent arsenic: 76
Arsenic Pentoxide, As205 (Anhydride of Arsenic Acid)
Physical state: deliquescent, white amorphous powder
Formula weight: 229,84
Specific gravity: 4,32
Melting point: decomposes at 315 C
Solubility, in g/lOOcc water: 150 at 16 C, 76,7 at 100 C
Percent arsenic: 65
Calcium Arsenate, Ca3(As04)2




Solubility, in g/lOOcc water: 0.013 at 25 C
Percent arsenic: 38; also occurs with 3 moles of water,




Copper Acetoarsenite, 3 Cu(As02)2-Cu(C00CH3)2 (approx)
(Copper Acetate Metarsenate, Imperial, Schweinfurth, Vienna, 
Parrot or Paris Green)
Physical state: emerald green powder
Formula weight: 1013.77
Solubility: insoluble in water
Percent arsenic: 44
Cupric Arsenite, CuHAs03 (approx) (Scheele's Green, Swedish Green) 
Physical state: yellowish green powder
Formula weight: 187,47
Melting point: decomposes
Solubility: insoluble in water
Percent arsenic: 40
Lead Arsenate, Pb3(As04)2 (Lead Orthoarsenate)
Physical state: white crystals
Formula weight: 899.41
Melting point: 1042 C, slightly decomposes at 1000 C
Solubility: very slightly soluble in cold water
Specific gravity: 7.8
Percent arsenic: 17
Lead Arsenite, Pb(As02)2 (Lead Metarsenite)
Physical state: white powder
Formula weight: 421,03
Specific gravity: 5.85
Solubility: insoluble in cold water
Percent arsenic: 36
Ortho-Arsenic Acid, H3As04-l/2H20
Physical state: white translucent hygroscopic crystals
Formula weight: 150,95
Specific gravity: 2.0 to 2.5
Melting point: 35.5 C
Boiling point: 160 C
Solubility, in g/lOOcc: 16.7 in cold water
50 in hot water
Percent arsenic: 50
Sodium Arsenite, NaAs02 (Sodium Metarsenite)
Physical state: gray-white powder
Formula weight: 129.91
Specific gravity: 1.87





OCCUPATIONS WITH POTENTIAL ARSENIC EXPOSURE
alloy makers 
aniline color makers 





cattle dip workers 







































1965 SMELTER SURVEY 
ATMOSPHERIC ARSENIC CONCENTRATIONS (mg As/cu m)













"Medium exposure areas" as classified by Lee and Fraumeni 
•eratorv Area Mean:












Treater Building and Arsenic Loading Mean:




"Light exposure areas" as classified by Lee and Fraumeni

























1965 SMELTER SURVEY 
URINARY ARSENIC








Louvre man (treater) 0.11
Louvre man (treater) 0.12
Dump floorman 0.40




Change floor operator 0.32
Cleaner 0.27
Funnel loader 0.43
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